Podcasts about clinical neurosciences

How do you turn massive clinical imaging data into insights that change lives? What does it take to move from a psychology undergrad to a pioneering role in pediatric brain research? And how can coding, connectomics, and curiosity shape a meaningful clinical career in neuroscience? In this inspiring episode of Neurocareers: Doing the Impossible!, we sit down with Dr. Puck Reeders, Senior Neuroscience Research Scientist at the Brain Institute at Nicklaus Children's Hospital. From her early days in Curacao to building novel neuroimaging pipelines in one of the nation's oldest pediatric epilepsy programs, Dr. Reeders shares her unique career path—and how she helps decode complex brain networks to improve surgical outcomes for children with intractable epilepsy. We explore: How connectomics and diffusion imaging guide surgical planning Her innovative research on white matter networks and neuromodulation responses The steep but rewarding path from zero coding skills to advanced tractography Tips for transitioning from psychology to clinical neuroscience Career advice for anyone eager to enter research-focused medical settings Whether you're a student exploring future careers, a neuroscientist curious about clinical impact, or just fascinated by how science meets medicine—you'll walk away informed and inspired. Chapters: 00:00:00 - Insights from a Neuroscience Research Scientist 00:03:00 - Functional Mapping Techniques for Epilepsy 00:08:43 - Transitioning from Medical School to Psychology 00:13:10 - Research Gaps in Epilepsy 00:17:10 - Understanding Connectomics in Epilepsy Treatment 00:21:53 - Combining Imaging Techniques in Research 00:24:50 - Coding Challenges in Research 00:27:12 - Coding Journey in Neuroscience 00:28:51 - Learning to Code: A Personal Journey 00:32:39 - The Importance of Networking 00:34:30 - Art's Role in Science Communication 00:37:38 - Landing a Job Through Networking 00:41:22 - Research Opportunities in Connectomics 00:46:49 - Exploring Diverse Career Opportunities 00:51:38 - Job Search Tips and Strategies 00:54:39 - Tips for Job Applications and Interviews 00:59:46 - From Medicine to Neuroscience Research 01:02:06 - Clinical Research and Pediatric Epilepsy About the Podcast Guest: Dr. Puck Reeders is a Senior Neuroscience Research Scientist at the Brain Institute at Nicklaus Children's Hospital in Miami, Florida https://www.nicklauschildrens.org/home Her work focuses on investigating aberrant brain networks in children with intractable epilepsy, applying advanced neuroimaging techniques to improve clinical outcomes in pediatric neurology. Originally from the Netherlands and raised on the island of Curaçao, Dr. Reeders brings a global perspective to her research. She holds a Bachelor of Science in Psychology and Chemistry from the University of Miami, and a PhD in Cognitive Neuroscience from Florida International University, where she also completed her postdoctoral training in the Allen Neurocircuitry and Cognition Lab. Dr. Reeders has over nine years of experience working with functional MRI (fMRI) and diffusion-weighted imaging (DWI) in both adults and children. Her current research explores the structural connectomics of pediatric epilepsy, the development of clinical imaging pipelines to detect white matter abnormalities, cortical dysplasias, and automated SPECT subtractions—bringing together cutting-edge science with translational clinical impact. Her expertise spans: Neuroimaging and clinical pipeline development Data analysis and scientific coding Translational neuroscience and surgical planning support Research project design and academic mentoring Outside of the lab, Dr. Reeders shares insights into neuroscience careers and research life on her educational Instagram: @Drpucky You can also connect with her professionally on LinkedIn:  https://www.linkedin.com/in/puckreeders/  About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

One in five people in Australia and New Zealand will experience chronic pain at some stage in their lives; and it's recognised as a major global health issue. Unrelieved pain can affect every area of a person's life with major social, financial and emotional consequences. Researchers at the University of New South Wales and Neuroscience Research Australia have done a randomised trial focusing on the experiences of people with chronic pain - and the role emotional processing plays in managing chronic pain conditions. Professor Lorimer Moseley is a professor of Clinical Neurosciences at the University of South Australia and the Chair of PainAdelaide. In this episode of Weekend One on One, he spoke with Peggy Giakoumelos on the role of psychology in chronic pain management.

In this episode, I speak with Professor Guy Leschziner, a consultant neurologist and author of three bestselling books, including: “The Man Who Tasted Words”, “The Secret World of Sleep”, and “The Seven Deadly Sins”, which this interview focuses on. Drawing on insights from evolutionary biology, genetics, and clinical neurology, Guy makes a compelling case that what we label as “sin” may often have a biological cause, and isn't necessarily a moral failing. Expect to learn: — Why our so-called “sins” evolved as adaptive traits—and why they still serve a purpose — How free will may be more of a spectrum than a binary — Why understanding the biology of behaviour could radically change the criminal justice system — The disturbing story of Robert Alton Harris—and what it reveals about judgment, compassion, and accountability And more. You can learn more about Guy's work at https://www.guyleschziner.com. --- Dr Guy Leschziner is a neurologist with special expertise in sleep disorders and epilepsy. Dr Leschziner is Consultant Neurologist at London Bridge Hospital and Clinical Lead for the Sleep Disorders Centre at Guy's and St Thomas' Hospital, London, one of the largest sleep units in Europe. He also practices at London Bridge Hospital and the Cromwell Hospital. He is also Reader in Neurology at the Department of Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London. Under the broad umbrella of sleep disorders, Dr Leschziner is a particular authority on narcolepsy, sleepwalking, Kleine-Levin syndrome and restless legs syndrome. Dr Leschziner is also enthusiastically engaged with public education through a wide range of media work. He presented a popular radio series for the BBC, Mysteries of Sleep, as well as The Secrets of Sleep for Channel 4 television in the UK. He has also been an expert commentator for BBC News and The Guardian. Dr Leschziner is also the author of several books: The Nocturnal Brain: Nightmares, Neuroscience and the Secret World of Sleep, The Man Who Tasted Words, and The Seven Deadly Sins. --- Interview Links: — Dr. Leschziner's website - https://www.guyleschziner.com — Dr. Leschziner's books: https://amzn.to/4dbnFru

Two wide open cases from the latest issue of the journal. Starting with a case from Italy (1:18), of a 63-yo man having a history of behavioural and cognitive problems since retiring. His many changes included low mood, significant weight loss, and problems with sleep and temperature regulation. He had a background of type 2 diabetes. Initial treatment was on a suspicion of Alzheimer's, but there was no clinical improvement. https://pn.bmj.com/content/25/2/159  A case from the United States is next (17:36), featuring a 66-yo lady experiencing 10 days of generalised weakness, with episodes of forgetfulness and a series of falls. She had previously been treated for left-sided ophthalmic herpes zoster. Neurological examination showed mild right arm and leg weakness. https://pn.bmj.com/content/25/2/164    The case reports discussion is hosted by Prof. Martin Turner¹, who is joined by Dr. Ruth Wood² and Dr. Babak Soleimani³ for a group examination of the features of each presentation, followed by a step-by-step walkthrough of how the diagnosis was made. These case reports and many others can be found in the February 2025 issue of the journal. (1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital. (2) Neurology Registrar, University Hospitals Sussex. (3) Clinical Research Fellow, Oxford Laboratory for Neuroimmunology and Immunopsychiatry, Nuffield Department of Medicine, University of Oxford Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. Production and editing by Brian O'Toole. Thank you for listening. 

Was wäre, wenn wir in Wirklichkeit gar nicht glücklich sein wollen? Wenn das Streben nach Glück Bullshit wäre? Obwohl wir alle denken „ich will doch glücklich sein“ oder „Glück fühlt sich toll an“ - könnte es doch auch sein, dass Glück am Ende nur ein PR-Trick ist… In dieser Folge kriegt ihr einen steile aber sehr spannende These. Fühlt euch gut betreut Leon & Atze Start ins heutige Thema: 09:48 min. VVK Münster 2025: https://betreutes-fuehlen.ticket.io/ Instagram: https://www.instagram.com/leonwindscheid/ https://www.instagram.com/atzeschroeder_offiziell/ Der Instagram Account für Betreutes Fühlen: https://www.instagram.com/betreutesfuehlen/ Mehr zu unseren Werbepartnern findet ihr hier: https://linktr.ee/betreutesfuehlen Tickets: Atze: https://www.atzeschroeder.de/#termine Leon: https://leonwindscheid.de/tour/ Quellen: Der Artikel von David Pinsof: Happiness Is Bullshit https://www.everythingisbullshit.blog/p/happiness-is-bullshit Und sein Fortsetzungsartikel dazu: Happiness Is Bullshit Revisited https://www.everythingisbullshit.blog/p/happiness-is-bullshit-revisited Die Argumentation von Andy Clark: Clark, A. (2024). The experience machine: How our minds predict and shape reality. Random House. Wer tiefer einsteigen will, zum Thema Vorhersagen in unserem Hirn und Belohnungen: Schultz, W. (2016). Dopamine reward prediction error coding. Dialogues in Clinical Neuroscience, 18(1), 23–32. Schultz, W. (2024). A dopamine mechanism for reward maximization. Proceedings of the National Academy of Sciences. Das passt zur Idee mit dem Topfschlagen: »Your Brain Predicts (Almost) Everything You Do«, schreibt Lisa Feldman Barrett in ihrem Buch und liefert eine Reihe von Argumenten und Beispielen. Barrett, L. F. (2023). Siebeneinhalb Lektionen über das Gehirn. Rowohlt. Und eben Andy Clark: Clark, A. (2024). The experience machine: How our minds predict and shape reality. Random House. Die Studie mit den Ratten: Warlow, S. M., Naffziger, E. E., & Berridge, K. C. (2020). The central amygdala recruits mesocorticolimbic circuitry for pursuit of reward or pain. Nature communications. Eine Übersicht zu Wanting vs. Liking Nguyen, D., Naffziger, E. E., & Berridge, K. C. (2021). Positive affect: nature and brain bases of liking and wanting. Current Opinion in Behavioral Sciences. Und hier nochmal tiefer mit Fokus auf Drogen Robinson, T. E., & Berridge, K. C. (2024). The incentive-sensitization theory of addiction 30 years on. Annual Review of Psychology, 76. Redaktion: Dr. Leon Windscheid Produktion: Murmel Productions

The latest guidelines on disease-modifying treatment in multiple sclerosis (MS) from the Association of British Neurologists is discussed in this intercontinental podcast with perspectives from the UK, the USA, and Australia.   Participants: Professor Alasdair Coles is Head of Department for Clinical Neuroscience and also Co-Director of the Cambridge Centre for Myelin Repair, UK. Dr. Tamara Kaplan is Assistant Professor of Neurology at Harvard Medical School, and is also affiliated with the Brigham and Women's Hospital, Boston, USA. Professor Michael Barnett is a consultant neurologist at Royal Prince Alfred Hospital Sydney, Central Clinical School, and Director of the RPAH MS Clinic and the MS Clinical Trials Unit at the Brain and Mind Centre, University of Sydney, Australia. Read the paper (https://pn.bmj.com/content/25/1/18) which is part of the February issue of the Practical Neurology journal.   Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. Production and editing by Letícia Amorim. Thank you for listening.     

Die Themen in den Wissensnachrichten: +++ 2022 höchster Textilverbrauch ever in der EU +++ Klimawandel für 1.000 Jahre simuliert +++ Mikroplastik in synthetischen und in natürlichen Kaugummis +++**********Weiterführende Quellen zu dieser Folge:Circularity of the EU textiles value chain in numbers, European Environment Agency, 25.03.2025Interplay between climate and carbon cycle feedbacks could substantially enhance future warming, Environmental Research Letters, 24.03.2025Chewing Gums: Unintended sources of ingested microplastics in humans, Frühjahrs-Konferenz der American Chemical Society, 25.03.2025Order–disorder transition in multidirectional crowds, PNAS, 24.03.2025Brain iron load and neuroaxonal vulnerability in adult attention-deficit hyperactivity disorder, Psychiatry and Clinical Neurosciences, 27.02.2025Alle Quellen findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .

In this episode, we sit down with Sarah Turner, CEO and co-founder of CeraThrive, to dive into the incredible benefits of red light therapy for both gut and brain health. Sarah shares her expertise on how red light therapy can support the body's natural healing processes and improve the health of the gut-brain axis. We explore the science behind this cutting-edge therapy, how it enhances cellular health, and practical tips for incorporating the CeraThrive into your daily routine. Whether you're looking to optimize gut health, support brain function, or boost overall well-being, this episode offers valuable insights into the healing power of light!Sarah Turner is an accomplished professional with an impressive educational background. She holds a postgraduate degree in Clinical Neuroscience from Roehampton University, London, and has earned BSc degrees in Psychological Sciences and Nutritional Medicine from Westminster University and Thames Valley University, respectively. Recently, she completed her diploma in PBM (Photobiomodulation) from Montpellier University, where she will particpate on the neurology module for the upcoming academic year. Sarah is the CEO and Co-Founder of the neurotech company, CeraThrive LLC - and the co-host of Rebel Scientist podcast.SHOW NOTES:0:39 Welcome to the podcast!2:31 Sarah Turner's bio3:13 Welcome Sarah to the show!4:15 Her background as a Neuroscientist5:22 Studying Parkinson's with Light8:18 Understanding the Gut-Brain Axis11:25 Symptoms of gut-brain dysfunction14:31 Why is there more mental health dysfunction?16:30 The evolution of light in our modern world20:32 Optimal wavelengths for healing26:35 All about the CeraThrive device!31:40 Low-level stress & antioxidants35:55 Stimulating the vagus nerve through the gut38:35 Why sleep requires energy40:58 Can red light override blue light exposure?44:37 Aligning your day with red light stacks49:37 Structured water for gut-brain health53:20 Recovering from Jet Lag55:00 How CeraThrive differs from other red light panels1:01:23 Where to find Sarah & CeraThrive1:02:41 Her final piece of advice1:04:45 Thanks for tuning in!RESOURCES:Website: CeraThrive - code: BIOHACKERBABES20IG: @CeraThriveLinkedIn: CeraThrive35 Best Biohacking PodcastsOur Sponsors:* Check out Effecty and use my code BIOHACKERBABES for a great deal: https://www.effecty.com* Check out Puori: https://puori.com/BIOHACKERBABESSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

Fitness trackers at the ready! Join James Gallagher at Cardiff Science Festival as he runs through the ways wearable tech is making an impact on health and how it might shape the future of medicines and care. With him are Dr Sanne Lugthart, Haematology consultant at the University Hospital of Bristol and Weston NHS Foundation Trust. She's pioneering using wearables and an app to track pain in people who suffer from sickle cell disease. Also on the panel is Professor Kathryn Peall who is Personal Chair, Division of Psychological Medicine and Clinical Neurosciences at Cardiff University. Kathryn tells James all about working with data from the UK Biobank to test if wearables could predict Parkinson's disease. She's also developing 80s-style headbands that could help take hospital grade sleep monitoring to the comfort of the bedroom. And, running experiments with the audience and on his skydiving assistant Danni, James is also joined by Damian Bailey, Professor of Physiology and Biochemistry from the University of South Wales.Presenter: James Gallagher Producers: Tom Bonnett and Hannah Robins Production Co-ordinator: Ishmael Soriano Editor: Colin Paterson

A puzzling pair of Case Reports from the most recent issue of the journal. First up (1:35) is a man in his mid-fifties, presenting with lumbar spine fractures, which then developed into confusion, vomiting, and abdominal pain. An x-ray showed  dilated intestinal loops and his blood sodium levels were low. https://pn.bmj.com/content/25/1/87 The second case (23:06) involves a 21-yo woman, who presented  at 18 weeks pregnant with  multiple episodes of right upper limb tonic extension, and subsequently developed new-onset refractory status epilepticus (NORSE). https://pn.bmj.com/content/25/1/56    The case reports discussion is hosted by Prof. Martin Turner¹, who is joined by Dr. Ruth Wood² and Dr. Xin You Tai³ for a group examination of the features of each presentation, followed by a step-by-step walkthrough of how the diagnosis was made. These case reports and many others can be found in the February 2025 issue of the journal. (1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital. (2) Neurology Registrar, University Hospitals Sussex. (3) Clinical Academic Fellow, Nuffield Department of Clinical Neurosciences, Oxford University, and Neurology Specialty registrar, Oxford University Hospital.  Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. Production and editing by Letícia Amorim and Brian O'Toole. Thank you for listening. 

Two more fascinating Case Reports from the latest issue of the journal. The first case (1:15) is of a 57-yo woman, with an intermittent posterior headache, which had an associated bilateral pressure-like sensation. Her symptoms had begun on a recent trip to Sri Lanka. https://pn.bmj.com/content/24/6/526  Following on is the second case (22:18), which features a 54-yo man experiencing deterioration in his speech and mobility. He had a background of chronic HIV infection with ongoing treatment. https://pn.bmj.com/content/24/6/507   The case reports discussion is hosted by Prof. Martin Turner¹, who is joined by Dr. Ruth Wood² and Dr. Xin You Tai³ for a group examination of the features of each presentation, followed by a step-by-step walkthrough of how the diagnosis was made. These case reports and many others can be found in the June 2024 issue of the journal. (1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital. (2) Neurology Registrar, University Hospitals Sussex. (3) Clinical Academic Fellow, Nuffield Department of Clinical Neurosciences, Oxford University, and Neurology Specialty registrar, Oxford University Hospital.  Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. Production and editing by Letícia Amorim and Brian O'Toole. Thank you for listening. 

In this episode, Jack and Peter discuss the future of work and whether returning to the office or working from home will be more successful in the age of AI.   Recorded on Dec 7th, 2024 Views are my own thoughts; not Financial, Medical, or Legal Advice. Jack Hidary is a leading entrepreneur and visionary at the forefront of AI and quantum technology as the CEO of SandboxAQ, raising over $500m in funding. He is the author of forthcoming book AI or Die and the influential textbook; Quantum Computing: An Applied Approach. A serial entrepreneur, Hidary co-founded and led EarthWeb/Dice from inception to IPO, and co-founded Vista Research and sold it to S&P/McGraw-Hill. Jack studied neuroscience at Columbia University and was a Stanley Fellow in Clinical Neuroscience at the NIH where he applied neural networks to brain imaging. Nadia Harhen is the General Manager of AI Simulation at SandboxAQ, where she harnesses the power of AI and quantum simulation to revolutionize drug, material, and chemical discovery. With over 15 years of experience spanning R&D, product management, and regulatory operations in the life sciences and technology sectors, she has driven innovations from combination device R&D at Johnson & Johnson to AI-based medical devices at Google. Nadia's leadership has secured regulatory clearance in 70+ countries, advanced groundbreaking therapies, and opened new markets for cutting-edge technologies. Learn more about SandboxAQ: https://www.sandboxaq.com/  Sandbox AQ's 3C Success: https://www.sandboxaq.com/press/sandboxaq-publishes-scientific-and-technical-milestones-for-quantitative-methods  Pre-Order my Longevity Guidebook here: https://longevityguidebook.com/  ____________ I only endorse products and services I personally use. To see what they are, please support this podcast by checking out our sponsors:  Get started with Fountain Life and become the CEO of your health: https://fountainlife.com/peter/ AI-powered precision diagnosis you NEED for a healthy gut: https://www.viome.com/peter  Get 15% off OneSkin with the code PETER at  https://www.oneskin.co/ #oneskinpod _____________ I send weekly emails with the latest insights and trends on today's and tomorrow's exponential technologies. Stay ahead of the curve, and sign up now: Blog _____________ Connect With Peter: Twitter Instagram Youtube Moonshots

The immune system is a recurring feature in the cases discussed in this edition of the Case Reports podcast. The first paper details the cases of two young women, sisters, presenting with overlapping conditions but resulting in tragically different outcomes (1:16). Both were in their twenties, had given birth recently, and developed limb weakness along with several other neurological symptoms. https://pn.bmj.com/content/24/5/422 Our second case is a 72-yo woman with a range of symptoms including diplopia, ptosis, myalgia, and worsening shortness of breath (21:27). She had had surgical resection of a malignant melanoma, and was receiving immunotherapy treatment. Her presentation resembled myasthenia gravis, but initial treatment did not yield a response. https://pn.bmj.com/content/24/5/428  The case reports discussion is hosted by Prof. Martin Turner¹, who is joined by Dr. Ruth Wood² and Dr. Xin You Tai³ for a group examination of the features of each presentation, followed by a step-by-step walkthrough of how the diagnosis was made. These case reports and many others can be found in the June 2024 issue of the journal. (1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital. (2) Neurology Registrar, University Hospitals Sussex. (3) Clinical Academic Fellow, Nuffield Department of Clinical Neurosciences, Oxford University, and Neurology Specialty registrar, Oxford University Hospital.  Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. This episode was produced and edited by Brian O'Toole. Thank you for listening. 

In this episode of CUBIST, the host discusses a study titled "Relationship Between Post-Traumatic Headache and Depression After Mild Traumatic Brain Injury," by Dr. Marissa Beal and colleagues, published in the Journal of Neuropsychiatry and Clinical Neurosciences in August 2024. Article Citation: Beal, M. L., Psoter, K. J., Bechtold, K. T., Nagpaul, V., Peters, M. E., Rao, V., Van Meter, T. E., Falk, H., Korley, F. K., & Roy, D. (2024). Relationship Between Posttraumatic Headache and Depression After Mild Traumatic Brain Injury. The Journal of Neuropsychiatry and Clinical Neurosciences, appineuropsych20230143. Advance online publication. https://doi.org/10.1176/appi.neuropsych.20230143 Article LINK: https://pubmed.ncbi.nlm.nih.gov/39113495/ Learn more about the Military Acute Concussion Evaluation 2 (MACE 2), the Progressive Return to Activity (PRA), and other clinical resources at Health.mil/TBIProviders. CUBIST is a podcast for health care providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views and opinions of findings and or devices discussed in this podcast are those of the host, subject matter experts, and or guests. Facts represented constitute our understanding at the time of the podcast, whereas updated factual information may be developed. They should not be construed as pronouncing an official Department of Defense's position, policy, decision, or endorsement. The hosts and guests of CUBIST may be defense contract personnel who support TBICoE. The status of all hosts and guests will be identified during introductions to the podcast. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.

In this episode of CUBIST, the host discusses a study titled "Relationship Between Post-Traumatic Headache and Depression After Mild Traumatic Brain Injury," by Dr. Marissa Beal and colleagues, published in the Journal of Neuropsychiatry and Clinical Neurosciences in August 2024. Article Citation: Beal, M. L., Psoter, K. J., Bechtold, K. T., Nagpaul, V., Peters, M. E., Rao, V., Van Meter, T. E., Falk, H., Korley, F. K., & Roy, D. (2024). Relationship Between Posttraumatic Headache and Depression After Mild Traumatic Brain Injury. The Journal of Neuropsychiatry and Clinical Neurosciences, appineuropsych20230143. Advance online publication. https://doi.org/10.1176/appi.neuropsych.20230143 Article LINK: https://pubmed.ncbi.nlm.nih.gov/39113495/ Learn more about the Military Acute Concussion Evaluation 2 (MACE 2), the Progressive Return to Activity (PRA), and other clinical resources at Health.mil/TBIProviders. CUBIST is a podcast for health care providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views and opinions of findings and or devices discussed in this podcast are those of the host, subject matter experts, and or guests. Facts represented constitute our understanding at the time of the podcast, whereas updated factual information may be developed. They should not be construed as pronouncing an official Department of Defense's position, policy, decision, or endorsement. The hosts and guests of CUBIST may be defense contract personnel who support TBICoE. The status of all hosts and guests will be identified during introductions to the podcast. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.

In this episode, Jack and Peter discuss how Quantum can become a business and current use cases of Quantum through AQMed, AQNav, and AQtive Guard.  Recorded on Oct 4th, 2024 Views are my own thoughts; not Financial, Medical, or Legal Advice. 10:05 | Quantum Sensors for Earth Navigation 28:56 | New Quantum Technology in Hospitals 42:02 | The Future of Quantum Computing Jack Hidary is a leading entrepreneur and visionary at the forefront of AI and quantum technology as the CEO of SandboxAQ, raising over $500m in funding. He is the author of forthcoming book AI or Die and the influential textbook; Quantum Computing: An Applied Approach. A serial entrepreneur, Hidary co-founded and led EarthWeb/Dice from inception to IPO, and co-founded Vista Research and sold it to S&P/McGraw-Hill. Jack studied neuroscience at Columbia University and was a Stanley Fellow in Clinical Neuroscience at the NIH where he applied neural networks to brain imaging. Learn more about SandboxAQ: https://www.sandboxaq.com/  ____________ I only endorse products and services I personally use. To see what they are,  please support this podcast by checking out our sponsors:  Get started with Fountain Life and become the CEO of your health: https://fountainlife.com/peter/ AI-powered precision diagnosis you NEED for a healthy gut: https://www.viome.com/peter  Reverse the age of your skin with Oneskin; 30% here: http://oneskin.co/PETER    _____________ Get my new Longevity Practices 2024 book: https://bit.ly/48Hv1j6  I send weekly emails with the latest insights and trends on today's and tomorrow's exponential technologies. Stay ahead of the curve, and sign up now:  Tech Blog _____________ Connect With Peter: Twitter Instagram Youtube Moonshots

In this episode, Jack and Peter discuss LQMs which are the next stage of AI beyond LLMs. LQMs are growing in applications in the biggest parts of the economy. Jack and Peter then talk about the synergy of bringing AI and quantum together for global impact. Recorded on Oct 1st, 2024 Views are my own thoughts; not Financial, Medical, or Legal Advice. 01:57 | The Future of AI and Quantum 31:41 | The Intersection of AI and Brain Imaging 01:04:46 | Decoding the Mysteries of Quantum Jack Hidary is a leading entrepreneur and visionary at the forefront of AI and quantum technology as the CEO of SandboxAQ, raising over $500m in funding. He is the author of forthcoming book AI or Die and the influential textbook; Quantum Computing: An Applied Approach. A serial entrepreneur, Hidary co-founded and led EarthWeb/Dice from inception to IPO, and co-founded Vista Research and sold it to S&P/McGraw-Hill. Jack studied neuroscience at Columbia University and was a Stanley Fellow in Clinical Neuroscience at the NIH where he applied neural networks to brain imaging. Learn more about SandboxAQ: https://www.sandboxaq.com/  ____________ I only endorse products and services I personally use. To see what they are, please support this podcast by checking out our sponsors:  Get started with Fountain Life and become the CEO of your health: https://fountainlife.com/peter/ AI-powered precision diagnosis you NEED for a healthy gut: https://www.viome.com/peter  Reverse the age of your skin with Oneskin; 30% here: http://oneskin.co/PETER    Get real-time feedback on how diet impacts your health with https://join.levelshealth.com/peter/ _____________ Get my new Longevity Practices 2024 book: https://bit.ly/48Hv1j6  I send weekly emails with the latest insights and trends on today's and tomorrow's exponential technologies. Stay ahead of the curve, and sign up now: Tech Blog _____________ Connect With Peter: Twitter Instagram Youtube Moonshots

The BPD Bunch is Back! Xannie, Jack, Mo, Jay, Hak Ja and André discuss how borderline personality disorder presents in Men and Women. Xannie and Jay start by sharing some of the research, to answer questions like: Is BPD different in men than women? How does BPD present in males? What are the symptoms of BPD in women? What is the prevalence of borderline personality disorder in women? Why is BPD misdiagnosed in men? Then the group discuss their personal experiences of BPD and how that intersects with their gender. Come back on Friday as we wrap up this topic, with a discussion on BPD/Gender misconceptions we'd love to challenge! October 9th we'll be back with a new discussion topic, dealing with BPD at School. Can't wait until then? Sign up for our "BPD Buddies" or "BPD Besties" tiers on Patreon to get early access to an exclusive extended cut of next week's episode NOW!

Just as you finally get everything under control, life throws you ANOTHER curve ball. Seems like no matter what you do, you never get a moment of peace bc It's Always Something. Discover exactly how to break down the elusive barriers that perpetually seem to get in the way of perfectionists and equip you with practical tools to let go of the chaos so you can navigate life's unexpected twists without getting overwhelmed.  On paper, you've got it together— isn't it time you felt like it? Whether it's becoming much more DECISIVE in everything you do, PRESENCE with your family or turning down the volume on self-criticism, Perfectionism Optimized, private 1-1 coaching gives you the life-long skills to *finally feel* as amazing on the inside as your life looks on the outside. Get your stress-free start today at https://courtneylovegavin.com/optimized Listen to the full episode to hear:How where you source your confidence from determines how well you adapt to life's surprisesWhy resourcing yourself mentally, emotionally + physically enables you  to handle unexpected challenges like a proThe secret to stop feeling like everything is always on your shoulders (this is way better than deep breaths) Resources Mentioned In Episode 238:Neuroplasticity (Perfectionism Rewired Ep. 178)Perfectionism Optimized 1-1 Private Coaching Citations/Sources:Green, C. S., & Bavelier, D. (2008). Exercising your brain: A review of human brain plasticity and training-induced learning. Psychology and Aging, 23(4), 692–701. https://doi.org/10.1037/a0014345Kummer, K., Mattes, A. & Stahl, J. Do perfectionists show negative, repetitive thoughts facing uncertain situations?. Curr Psychol (2023). https://doi.org/10.1007/s12144-023-04409-3‌Levine, S. (2003). Psychological and social aspects of resilience: a synthesis of risks and resources. Dialogues in Clinical Neuroscience, 5(3), 273–280. https://doi.org/10.31887/dcns.2003.5.3/slevine 

Click here to subscribe for our podcast and video content on YouTube. This episode is an interview with Roger Barker, Professor of Clinical Neuroscience and Honorary Consultant in Neurology, at the University of Cambridge and Addenbrooke's Hospital. Dr. Barker is known for his groundbreaking work combining basic research on novel therapies for chronic neurodegenerative disorders, like Parkinson's, with clinical studies aimed at better defining these conditions.  For more information about the Davis Phinney Foundation visit: https://dpf.org This content is made possible through the generous support of listeners like you. Click here to make a donation. Season 5 Episode 28

This month's cases both feature sudden onset neurological syndromes. The first case (1:23) is that of a 26-yo Brazilian man who awoke from sleep with weakness in all four limbs. The signs suggest a possibility of Guillain-Barré syndrome or polio. A normal cranial nerve examination follows, with no unusual findings - https://pn.bmj.com/content/24/4/342  A 69-yo woman is the subject of the second case (14:33), after she presents with sudden onset unsteadiness and slurred speech when getting out of bed. A stroke was initially examined for by CT head scan, proving unremarkable, but a subsequent MRI scan showed an intense midbrain lesion. The patient subsequently improved, but then returned three months later with occurrences of the same symptoms multiple times throughout the day - https://pn.bmj.com/content/24/4/310 The case reports discussion is hosted by Prof. Martin Turner (1), who is joined by Dr. Ruth Wood (2) and Dr. Xin You Tai (3) for a group examination of the features of each presentation, followed by a step-by-step walkthrough of how the diagnosis was made. These case reports and many others can be found in the August 2024 issue of the journal. (1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital. (2) Neurology Registrar, University Hospitals Sussex. (3) Clinical Academic Fellow, Nuffield Department of Clinical Neurosciences, Oxford University, and Neurology Specialty registrar, Oxford University Hospital.  Listen to the JNNP podcast, "Nutritional peripheral neuropathies, with Dr. Alexander Rossor" on Apple (https://apple.co/3WjTmrM), Spotify (https://spoti.fi/4bKOhNA), Web (https://bit.ly/4cYhx4m). Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. This episode was produced and edited by Brian O'Toole. Thank you for listening. 

Neuroscience explains so much about our ADHD brain and the many traits, tendencies, and behaviours that come along for the ride. The more we understand our beautiful yet complex neurobiology, the more empowered we are to make sustainable and manageable changes to better enhance our lives.So, I'm delighted to welcome this week's guest, Nicole Vignola, a neuroscientist, author, consultant, and brain performance coach, to the podcast.Nicole's first book, Rewire: Your Neurotoolkit for Everyday Life is available now.On today's episode of The ADHD Women's Wellbeing Podcast, Kate and Nicola speak about:The science behind meditationThe brain's negativity biasThe function of the brain's 'DMN' AND 'TPN'How self-interruptions affect our daily lifeThe power of meditation for emotional regulationNicole's tips for feeling more calm and positiveFeeling more self-alignedThe damaging effects of your phone and social mediaWays to be more mindful of your phone usageUnderstanding dopamine betterThe life-changing benefits of a healthier sleep routineHow hydrating first thing can be essential for the ADHD brainHow visualising works in the brain and how it can improve our habitsAphantasia and learning how to visualiseYou can find out more about Nicole via her website, www.nicolesneuroscience.com.My other guest on today's ADHD Women's Wellbeing episode is Dr Lotta Borg Skoglund. We are at the cusp of new understandings about combining medical disciplines so we can understand ADHD in girls and women better through the lens of both menstrual cycles, hormones and psychiatry. This is for the lost generation of women who never got answers and for the future generations of girls who deserve better medical knowledge and research. Lotta is an associate professor in psychiatry at the Department of Women and Children's Health at Uppsala University and an affiliated researcher at the Department of Clinical Neuroscience at Karolinska Institutet. She is the author of six popular science books on ADHD and addiction, and her book ADHD Girls to Women - Getting on the Radar has been translated into several European languages, English and Korean.On this episode of the ADHD Women's Wellbeing Podcast, Dr Lotta Skoglund and Kate spoke about:Feeling abandoned by healthcare professionals after an ADHD diagnosisWhy healthcare professionals should be working together to help patientsHow an understanding of ADHD can change your health outcomesBuilding autonomy to feel more empowered with our ADHDImproving female-based medical research and ADHDThe importance of talking about your experiences with hormones to help othersPrecision and patient-led medicineConnecting Hormones and Psychiatry to help more ADHD womenWhy fluctuating hormones and cycles need to be part of the bigger health pictureGetting to know your unique hormone cycle traitsHow you can create a personalised health journalYou can learn more about Lotta's work via her website, www.borgskoglund.com and Letterlife.

Dr. Erik Reis is a Doctor of Chiropractic Medicine and Board-Certified Chiropractic Neurologist at The Neural Connection. He received his Doctorate in Chiropractic from Northwestern Health Sciences University, graduating with magna cum laude honors, and graduated from the University of Minnesota with his Bachelor of Science degree in Kinesiology/Exercise Science, with an emphasis in human motor performance in both athletic and therapeutic settings. Dr. Reis currently holds a Diplomate in Functional Neurology from the American Chiropractic Neurology Board and is a Certified Brain Injury Specialist through the Brain Injury Association of America. He has completed thousands of hours of additional post-graduate coursework utilizing clinical applications and therapeutic interventions in the neurological and nutritional rehabilitation of traumatic brain injuries, concussions, and vestibular disorders through the Carrick Institute of Clinical Neuroscience. https://theneuralconnection.com/ Enjoying this podcast? Please consider supporting it for just $5 through www.buymeacoffee.com/amyz

Two highly unusual cases in this edition of Case Reports. The first case describes a 64-yo woman presenting to the emergency department with a five day history of bizarre behaviours (1:45). A BBC radio show prompts her, out of character, to reflect aloud about her childhood, and she experiences recurrent periods of unresponsiveness followed by intense agitation. She was kept in hospital for scans and discharged after two weeks, but returned soon after with a similar presentation - (link) A lifetime bodybuilder is the patient in the second case (21:12), with a practice of anabolic steroid injection over several decades. He presents with a three year history of unsteadiness when walking and tingling in his feet, as well as reduced dexterity. His symptoms are found to be brought on by a toxicity from an unexpected source - (link) The case reports discussion is hosted by Prof. Martin Turner (1), who is joined by Dr. Ruth Wood (2) and Dr. Xin You Tai (3) for a group examination of the features of each presentation, followed by a step-by-step walkthrough of how the diagnosis was made. These case reports and many others can be found in the June 2024 issue of the journal. (1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital. (2) Neurology Registrar, University Hospitals Sussex. (3) Clinical Academic Fellow, Nuffield Department of Clinical Neurosciences, Oxford University, and Neurology Specialty registrar, Oxford University Hospital.  Listen to the JNNP podcast, "Nutritional peripheral neuropathies, with Dr. Alexander Rossor" on Apple (https://apple.co/3WjTmrM), Spotify (https://spoti.fi/4bKOhNA), Web (https://bit.ly/4cYhx4m). Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. This episode was produced and edited by Brian O'Toole. Thank you for listening. 

In our previous episode, we explored the scientifically documented benefits of ayahuasca in a deep-dive interview with Sheryl Attig, Ph.D. I recommend taking in that episode before you experience this one. This is Part Two of our discussion. Here, Sheryl expands beyond ayahuasca to include the benefits of LSD, psychedelic mushrooms, and more. As I noted last time, Sheryl is an expert on the benefits and dangers of ayahuasca and other psychedelics. She even serves as an expert witness in psychedelic-related legal matters.  I love how Sheryl's eloquence and keen intellect make all this easy to understand. I also appreciate that her years of personal experience with psychedelics give her an insider's perspective. My Resources Free video: Instant Divine Assistance: Your Free Guide to Fast and Easy Awakening, Healing, and More. I lead you through all four types of my invocations! Learn about VIP Day: your potent opportunity for profound personal transformation! Check out my #1 Amazon bestseller: Instant Divine Assistance: Your Complete Guide to Fast and Easy Spiritual Awakening, Healing, and More.  Available as an audiobook narrated by yours truly. (FREE if you're not yet an Audible member!) Also available as an eBook, paperback, and hardcover starting at $3.99, and included with Kindle Unlimited. Every month, I give away a free one-year Awakening Plus membership to an “Awaken, Heal, and Thrive!” listener. Click here to enter! “Awakening Plus” online membership Sheryl's Resources Attig, S. (under review). The spiritual significance of psychedelics. The Journal of Transpersonal Psychology. Bouso, J.C., Gonzalez, D., Fondevila, S., Cutchet, M., Fernandez, X., Barbosa, P.C.R., Alcazar-Corcoles, M.A., Araujo, W.S., Barbanoj, M.J., Fabregas, J.M., & Riba, J. (2012). Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: A longitudinal study. Plos One, 7(8)1-13. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0042421 Daldegan-Beuno, D., Revesz, D., Morais, P.R., Barbosa, P.C.R., & Maia, L.O. (2022). Psychosocial and drug use assessment of regular vs. non-regular ayahuasca users in a Brazilian sample: a web-based survey. Substance Use & Misuse, 57(7), 1072-1081. https://www.tandfonline.com/doi/full/10.1080/10826084.2022.2063896 Dos Santos, R.G., & Hallak, J.E. (2017). Effects of the natural β-Carboline alkaloid harmine, a main constituent of the ayahuasca, in memory and in the hippocampus: A systematic literature review of preclinical studies. Journal of Psychoactive Drugs, 49(1), 1-10. https://www.tandfonline.com/doi/full/10.1080/02791072.2016.1260189 Fonseca, A.M., Dos Santos, R.G., De Mederios, L.S., Veiga, T.A.M., Casses, F., Bruniera, C.P., Rossi, G.N., Bouse, J.C., Hallak, J.E.C., Santos, F.P., Paranhos, B.A.P.B., Yonamine, M., Rodrigues, E. (2023). Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users. European Archives of Psychiatry and Clinical Neuroscience.https://link.springer.com/article/10.1007/s00406-024-01817-9 Maia, L.O., Daldegan-Bueno, D., WieBner, I., Araujo, D.B., Tofoli, L.F. (2023). Ayahuasca's therapeutic potential: What we know – and what not. European Neuropsychopharmacology, 66, 45-61. https://www.sciencedirect.com/science/article/abs/pii/S0924977X22008847?via%3Dihub Ona, G., Kohek, M., Massaguer, T., Gomariz, A. Jimenez, D.F., Dos Santos, R.G., Hallak, J.E., Alcazar-Corcoles, M.A., & Bouso, J.C. (2019). Ayahuasca and public health: Health status, psychological well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users. Journal of Psychoactive Drugs, 51(2, 135-145. https://www.tandfonline.com/doi/full/10.1080/02791072.2019.1567961 A 60-minute talk followed by 29 minutes of questions and answers with astrobiologist Dr. Bruce Damer. He describes growing up with Asperger's Syndrome, being healed of it with ayahuasca, harnessing his innate visioning powers, and combining it with visions given by ayahuasca -- ultimately leading him to a groundbreaking new theory about the emergence of life on earth. The focus of the talk is using psychedelics to enhance creativity and problem solving. ESPD '55 Dr. Bruce Damer presents It's High Time For Science (5/25/2022). https://www.youtube.com/watch?v=gUQCrakiRqA  

Despite many of us feeling challenged by undiagnosed ADHD for most of our lives, there is also a way to thrive alongside our ADHD. On today's episode, I talk to Dr Miguel Toribio-Mateas, known affectionately as "The Creative Scientist," a distinguished clinical neuroscientist and nutrition researcher in the UK. His expertise centres on the intricate gut-brain connection, drawing on a rich, real-world scientific foundation rather than purely academic pursuits. Dr. Miguel's academic journey includes degrees in Nutritional Medicine and Clinical Neuroscience, culminating in a Doctorate focused on Mental Health and the Gut Microbiome. Navigating life with ADHD and autism, Dr Miguel possesses a deep, personal understanding of the specific dietary needs of neurodivergent individuals. He emphasises the critical role of dietary choices in enhancing executive functioning, sensory processing, and emotional regulation. His philosophy is captured in his words: “By understanding and addressing the nuanced relationships between what we eat and how our brains operate, we empower ourselves to make choices that not only nourish our bodies but also support our neurodivergent minds in navigating daily tasks and interactions more smoothly.”On today's ADHD Women's Wellbeing Podcast, Dr Miguel and Kate spoke about:Miguel's journey to his ADHD diagnosis Bringing a more feminine softer energy to science The relationship between the gut and the BrainADHD and disordered eating ADHD tendencies toward extreme behaviour Having self-compassion around your diet and what you eatHow self-compassion can actually help your gut health Identifying sources of rejection sensitivity dysphoria Dr Miguel offers personalized clinical consultations and has crafted a comprehensive course titled "Thrive with ADHD," available at drmiguelmateas.com/thrive-with-adhd-course. To discover more about his transformative work and offerings, visit drmiguelmateas.com or connect with him through social media for further insights.Look at some of Kate's ADHD workshops and free resources here.Kate Moryoussef is a women's ADHD Lifestyle & Wellbeing coach and EFT practitioner who helps overwhelmed and unfulfilled newly diagnosed ADHD women find more calm, balance, hope, health, compassion, creativity, and clarity. Follow the podcast on Instagram here.Follow Kate on Instagram here.Find Kate's resources on ADDitude magazine here.

Ayahuasca, more than anything else, has helped me continuously turbocharge my healing, awakening, and ever-increasing service capacity. But does objective scientific research show similar benefits for others? In this 43-minute episode, I explore this question with Sheryl Attig, Ph.D. She's an expert on the benefits and dangers of ayahuasca and other psychedelics. She even serves as an expert witness in psychedelic-related legal matters.  I love how Sheryl's eloquence and keen intellect make all this easy to understand. I also appreciate that her years of personal experience with psychedelics give her an insider's perspective. This is the first of two episodes featuring Sheryl. In this one, we focus on the scientifically documented benefits and dangers of ayahuasca. Next time, we'll expand our discussion to include LSD and magic mushrooms.  My Resources Free video: Instant Divine Assistance: Your Free Guide to Fast and Easy Awakening, Healing, and More. I lead you through all four types of my invocations! Learn about VIP Day: your potent opportunity for profound personal transformation! Check out my #1 Amazon bestseller: Instant Divine Assistance: Your Complete Guide to Fast and Easy Spiritual Awakening, Healing, and More.  Available as an audiobook narrated by yours truly. (FREE if you're not yet an Audible member!) Also available as an eBook, paperback, and hardcover starting at $3.99, and included with Kindle Unlimited. Every month, I give away a free one-year Awakening Plus membership to an “Awaken, Heal, and Thrive!” listener. Click here to enter! “Awakening Plus” online membership Sheryl's Resources Attig, S. (under review). The spiritual significance of psychedelics. The Journal of Transpersonal Psychology. Bouso, J.C., Gonzalez, D., Fondevila, S., Cutchet, M., Fernandez, X., Barbosa, P.C.R., Alcazar-Corcoles, M.A., Araujo, W.S., Barbanoj, M.J., Fabregas, J.M., & Riba, J. (2012). Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: A longitudinal study. Plos One, 7(8)1-13. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0042421 Daldegan-Beuno, D., Revesz, D., Morais, P.R., Barbosa, P.C.R., & Maia, L.O. (2022). Psychosocial and drug use assessment of regular vs. non-regular ayahuasca users in a Brazilian sample: a web-based survey. Substance Use & Misuse, 57(7), 1072-1081. https://www.tandfonline.com/doi/full/10.1080/10826084.2022.2063896 Dos Santos, R.G., & Hallak, J.E. (2017). Effects of the natural β-Carboline alkaloid harmine, a main constituent of the ayahuasca, in memory and in the hippocampus: A systematic literature review of preclinical studies. Journal of Psychoactive Drugs, 49(1), 1-10. https://www.tandfonline.com/doi/full/10.1080/02791072.2016.1260189 Fonseca, A.M., Dos Santos, R.G., De Mederios, L.S., Veiga, T.A.M., Casses, F., Bruniera, C.P., Rossi, G.N., Bouse, J.C., Hallak, J.E.C., Santos, F.P., Paranhos, B.A.P.B., Yonamine, M., Rodrigues, E. (2023). Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users. European Archives of Psychiatry and Clinical Neuroscience.https://link.springer.com/article/10.1007/s00406-024-01817-9 Maia, L.O., Daldegan-Bueno, D., WieBner, I., Araujo, D.B., Tofoli, L.F. (2023). Ayahuasca's therapeutic potential: What we know – and what not. European Neuropsychopharmacology, 66, 45-61. https://www.sciencedirect.com/science/article/abs/pii/S0924977X22008847?via%3Dihub Ona, G., Kohek, M., Massaguer, T., Gomariz, A. Jimenez, D.F., Dos Santos, R.G., Hallak, J.E., Alcazar-Corcoles, M.A., & Bouso, J.C. (2019). Ayahuasca and public health: Health status, psychological well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users. Journal of Psychoactive Drugs, 51(2, 135-145. https://www.tandfonline.com/doi/full/10.1080/02791072.2019.1567961 A 60-minute talk followed by 29 minutes of questions and answers with astrobiologist Dr. Bruce Damer. He describes growing up with Asperger's Syndrome, being healed of it with ayahuasca, harnessing his innate visioning powers, and combining it with visions given by ayahuasca -- ultimately leading him to a groundbreaking new theory about the emergence of life on earth. The focus of the talk is using psychedelics to enhance creativity and problem solving. ESPD '55 Dr. Bruce Damer presents It's High Time For Science (5/25/2022). https://www.youtube.com/watch?v=gUQCrakiRqA  

This time on the Anatomy in Clay® Learning System podcast, a chat with a renowned brain and neuroscience researcher on the power of hands-on learning. Dr. Kelly Lambert, a first-generation college student, received her undergraduate degree from Samford University in Birmingham AL (majoring in psychology and biology) in 1984 and her M.S. and Ph.D. in the field of Biopsychology from the University of Georgia in 1988. After spending 28 years at Randolph-Macon College in Ashland, Virginia where she served as the Macon and Joan Brock Professor and Chair of the Psychology Department (for 17 years), Co-Director of Undergraduate Research, and Director of the Behavioral Neuroscience Major, she joined the faculty at the University of Richmond as Professor of Behavioral Neuroscience in 2017. Dr. Lambert enjoys teaching courses such as Behavioral Neuroscience, Clinical Neuroscience, Comparative Animal Behavior, Neuroplasticity, and Psychobiology of Stress.  Dr. Lambert has won several teaching awards including the 2023 Soceity of Neuroscience Science Educator Award and the Virginia Professor of the Year for 2008. More:   Intro and Outro music "Vicious Pen" courtesy of Moby Gratis

We speak with neuroscientist Brooke Quinn, who is currently getting her Master's degree in sleep medicine from Oxford University, about sleep and the ADHD woman. Women with ADHD can be predisposed to not get good sleep, and inadequate sleep can lead to an increase of ADHD symptoms (even in neurotypical people), so the vicious cycle can be difficult and magnify ADHD symptoms. As a woman with ADHD herself, Brooke has been a pioneer in advocating for more research about sleep, women, and ADHD, and how they intersect: she goes down the rabbit hole for all of us who don't have the knowledge or bandwidth! Once again, we echo the refrain we've discussed with so many professionals on our show: So many of us have flown under the radar, felt alone, and have experienced a lack of understanding and resources. We are stronger when we talk about it!Brooke explains the impact of poor sleep on the emotional regulation of women with ADHD, including lower frustration tolerance, irritability, stress, and anger. Brooke talks to us about ADHD, motherhood, postpartum hormones, rage, irritability, and mood regulation, and also the shame and guilt that happens when we are sleep deprived and lose our cool. We talk through sleep tools and supplements, bedtime routine, sleep hygiene, and what to do in the middle of the night. Brooke Quinn's journey in the field of sleep medicine is paved with a rich tapestry of academic excellence, professional dedication, and a heartfelt commitment to the well-being of her clients. With 3 degrees in Sleep Medicine & Clinical Neurosciences, Brooke's academic journey reflects her unwavering curiosity and dedication to her field.Her academic prowess was further honed through clinical research coursework in 2018, culminating in her current pursuit of an MSc in Sleep Medicine Clinical Neurosciences from the prestigious University of Oxford. Guided by Brooke's philosophy that curiosity is the engine of achievement, Coastal Somnology Consulting prides itself on a relentless pursuit of knowledge and excellence in the field of sleep medicine. At Coastal Somnology Consulting, nestled on the coast of North Carolina, our journey into the realm of sleep medicine is driven by a deep-seated passion for helping others achieve optimal sleep health.Brooke Quinn's passion for sleep medicine is matched only by her love for her family, her animals, and the ocean. With 10 chickens, 2 ducks, 2 dogs, and a supportive family that includes a 4 year old son and a very tolerant spouse.  For Brooke, the ocean is more than just a happy place; it's a source of inspiration, reflection, and rejuvenation.www.coastalsomnologyconsulting.combquinn@coastalsomnologyconsulting.comtiktok & Instagram: @NeurospicyNeuroscientistTo Join us in the next Body Doubling Session, click here to sign up for the FREE ADHD Moms Club.MOTHER PLUS INSTAGRAM: https://www.instagram.com/mother_plus_podcast/MOTHER PLUS FACEBOOK: https://www.facebook.com/motherpluspodcastMOTHER PLUS PERMISSION SLIP: https://www.motherplusser.com/Permission-SlipMOTHER PLUS NEWSLETTER: https://www.motherplusser.com/signup-pageMOTHER PLUS BLOG: https://www.motherplusser.com/blog

Steve Davis This week on the podcast, I'm thrilled to bring you my conversation with Steve Davis, otherwise known as my dad!  Dad and I are very close and this is really an informal conversation where I wanted to ask dad some of the biggest things he's learned about living well as he recently turned 75, despite appearing as though he is in his 50s.  Professor Stephen Davis AO is the Professor of Translational Neuroscience at the University of Melbourne, Director of the Melbourne Brain Centre at the Royal Melbourne Hospital and Co-Chair of the Australian Stroke Alliance.   His research is focussed on acute therapy for both ischemic stroke and intracerebral hemorrhage, particularly the use of advanced imaging in selection of therapy. He is a consulting editor for Stroke and serves on editorial boards of the International Journal of Stroke, the European Stroke Journal and the Journal of Clinical Neuroscience. Learn more about Dad's career to date check out Episode 200. Our Sponsor Neon Treehouse is our major sponsor and partner in production. They are the go to full service digital marketing agency in Australia, for bright and imaginative solutions.  Promotional Partnerships Like what we are serving up on Humans of Purpose? Our promotional campaigns have delivered great marketing and sales outcomes and ROI for our partners to date.  Whether you're seeking a 1-month, 2-month or season sponsorship, follow the flow below to become a partner before we run out of our remaining promotional slots for 2024.  Click Here to learn more about collaborating on a custom campaign package. Ready to partner? Just complete this short Partner Enquiry Form and we'll be in touch. Gold Membership Want a premium listening experience that directly supports us to keep making the podcast?  Join current members Michael, Pravati, Noel, Kathy, Andrew 1, Andrew 2, Chris, Nikki, Margaret, Ben, Misha, Sarah and Geoff and enjoy our range of member benefits:  Premium dedicated podcast feed Removal of all three ads per episode Early access to all episodes Full transcripts of all episodes Brokered intros to all podcast guests Ask me anything page access To take up this great offer, just head to our Gold Member page today.

The majority of children and adolescents experience headache, with pooled estimates suggesting that approximately 60% of youth are affected. Migraine and tension-type headache are the leading cause of neurologic disability among children and adolescents 10 years and older. In this episode, Allison Weathers, MD, FAAN speaks with Serena Orr, MD, MSc, FRCPC, author of the article “Headache in Children and Adolescents,” in the Continuum® April 2024 Headache issue. Dr. Weathers is a Continuum® Audio interviewer and an associate chief medical information officer at Cleveland Clinic in Cleveland, Ohio. Dr. Orr is an assistant professor in the departments of Pediatrics, Community Health Sciences, and Clinical Neurosciences at Cumming School of Medicine, University of Calgary and a pediatric neurologist at Alberta Children's Hospital in Calgary, Alberta, Canada. Additional Resources Read the article: Headache in Children and Adolescents Subscribe to Continuum: continpub.com/Spring2024 Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @SerenaLOrr Transcript   Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, a companion podcast to the journal. Continuum Audio features conversations with the guest editors and authors of Continuum, who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article by visiting the link in the show notes. Subscribers also have access to exclusive audio content not featured on the podcast. As an ad-free journal entirely supported by subscriptions, if you're not already a subscriber, we encourage you to become one. For more information on subscribing, please visit the link in the show notes. AAN members, stay tuned after the episode to hear how you can get CME for listening.  Dr Weathers: This is Dr. Allison Weathers. Today, I'm interviewing Dr. Serena Orr on pediatric headache, which is part of the April 2024 Continuum issue on headache. Dr. Orr is an Assistant Professor at the University of Calgary, and a Pediatric Neurologist at Alberta Children's Hospital in Calgary, Alberta, Canada. Welcome to the podcast. So, thank you, Dr. Orr, for taking the time to speak with me about this fantastic article that covers such an important topic – headache in the pediatric population, in children and adolescents. First, I'd love to start by learning a little bit about you. Where do you practice, and how did you get interested in this topic? I love learning more about the authors of these incredible articles and how they became interested in their fields. So, you know, pediatric neurology is already a pretty subspecialized area of medicine – how did you become interested even further subspecializing in headache? Dr Orr: Well, thank you for the invitation. Nice to meet you, Dr. Weathers. I'm Serena Orr. I'm a clinician-scientist, pediatric neurologist, and headache specialist based in Canada at the Alberta Children's Hospital in Calgary, Alberta, just outside of the Rockies. I'm really passionate about headache medicine. I think I came to it because it allowed me to marry my interests in neurology and psychology together. I did my undergraduate studies at McGill in psychology and really wanted to take a biopsychosocial approach to my practice. The first child neurology patient I ever saw was a child who was experiencing migraine and having a lot of disability from it, with lots of impacts on her life - and I really saw an opportunity to take a holistic approach to the patient and marry my interests in neuroscience, neurology, and psychology together. So, I'm very excited to talk to you today about this topic that I'm really passionate about and that I think is underserved – um, hopefully get more people excited about it. Dr Weathers: But so great, and I'm sure we will do that just based on how excited I was just reading your article. So, I always like to start, actually, with what you feel is the most important clinical message of your article. What is your biggest takeaway you want to leave our listeners with? Dr Orr: Yeah, well I think this is a really big topic in neurology. So, if you look at the reasons for consulting a child neurologist, headache falls into the top three. 60% of youth experience headache in youth. If we look at what presents to neurology in terms of headache, the majority is migraine – and so that's a big focus of this article, because anywhere between a half to 88% of headache consultations in neurology are for migraine. And as I kind of alluded to in discussing my interests in this area, you know, it's really important to take a biopsychosocial approach to managing any chronic pain disorder, including migraine and headache disorders. Another big takeaway point from the article is that - specific to pediatric headache - there's really high placebo response rates that we're still trying to understand and grapple with in the field, and I think this underscores the importance in really doing patient-centered care and ensuring that you're educating patients and families about the level of evidence that we have about the placebo response rates and engaging in shared decision-making when you're choosing treatments together. So, I think those would be the main take-home points. Dr Weathers: I think both really critical. And I think even without – I'll put my plug in – even without the placebo effect, I think that shared decision-making is such an important concept for all of us in neurology to think about - but I think you make such the important point that with it, it becomes absolutely critical. I want to expand on a concept that you were just talking about. Pediatric headaches are so incredibly common, and you make the point in the article so well that they're one of the leading causes of neurological disability in pediatric patients. They have such a significant impact that really touches all aspects of these children's lives - both at school, how they impact their hobbies - pretty much everything that they do, and these long-reaching impacts. But then you go on to say that pediatric headache remains the most underfunded pediatric disease category when you take into account allocated public research dollars, which was just staggering to me. Why do you think this is? Dr Orr: I think there's a few reasons. So, one of the main reasons, I think, is that headache medicine has been underserved - there haven't been enough people who have gravitated to this field. I think this is rapidly changing as we train more people and show the world how important this topic is and how much exciting translational research is going on. But, historically, this has been a very small subspecialty that's been underserved relative to disease burden (so not enough scientists equals less research funding) - but there's another aspect to this as well. There was a paper published in 2020 by Mirin – who actually looked at research dollars in NIH based on disease burden and whether the diseases were male or female dominant - and found that there's a significant gender bias in research funding. Male-dominant diseases tend to be significantly overfunded relative to female-dominant diseases when you look at disease burden - and if you look at the female-dominant disease table, headache disorders and migraine are in the top three most underfunded disease categories amongst the underfunded female-dominant diseases. That data has been replicated looking at NIH dollars on the pediatric side as well. They didn't look at gender breakdown in the pediatric paper that was published a couple of years ago, but found, actually, that pediatric headache disorders are the most underfunded in terms of NIH research dollars to pediatric diseases – so, top underfunded relative to disease burden. So, yeah, being underserved as a field - and then, I think, gender bias has also played a significant role in what gets funded over time. Dr Weathers: Wow, that is hard to think about. And I think those are really insightful points and ones we really need to think about as we think about the bias in our research and our funding. Why is access to care and treatment for these children and adolescents so important? I know this seems like a super obvious one, but it feels like the answer is actually really much more complex. Dr Orr: Well, there's data to show that earlier diagnosis can lead to better long-term outcomes for youth with migraine - and this is really important, because if you look at the incidence curves for migraine, you see that at least a third, if not more, of incident cases occur before adulthood. We also know there's some GWAS data to show that youth-onset migraine has a higher genetic loading when looking at polygenic risk scores than adult-onset migraine, so people who have migraine onset in youth may be more genetically loaded (that may be important). And we also know that early access to diagnosis and treatment gives them a better long-term prognosis. We know that headache disorders and migraine are associated not only with long-term potential for disability on the physical side, but also increase the risk of psychiatric comorbidities developing over time, so there's really a huge opportunity in accessing a diagnosis and treatment early to improve long-term function - both on the medical side, but also potentially avert poor mental health outcomes - and also diagnose and treat a subset of people with the disease that may be more genetically loaded. We don't know if that impacts outcomes, but potentially, it does. So there's lots of reasons, I think, that we can get in there early and make a big impact – and even for those who it takes a while to find effective treatment for, really having access to education early so that they understand their disease and also ways that they can engage in self-management strategies, I think, is really empowering to the patient and really important (even if we're struggling to find the best medical therapy). Dr Weathers: You laid out a lot of really important reasons, and again, it goes back to the arguments made at the beginning about why it's so important to increase the funding so that this is no longer an area that's underserved, so that we are able to increase the access, and that everybody who needs this kind of care is able to get it. I want to shift a little bit and think about how we diagnose and work up patients who present with a headache. So as a neurologist - and also as a parent - one of the scariest considerations for me is figuring out if a headache is just a headache or if it's a sign of something else (you know, what we think of as a secondary headache disorder). What is your approach to distinguishing between the two? Dr Orr: We take a very clinical approach to diagnosis. We don't have specific biomarkers for different headache disorders, so we're still, you know, relying on a really detailed history and physical exam in order to sort out the diagnosis. As I discussed in the article, really the key first branch point (like you say) is, is this a primary headache disorder or a secondary headache disorder? There's some tools that we can use in practice to try to get at that, I think the most useful of which is the SNOOP tool - it's an acronym that goes over headache, red and orange flags. Every time I write an article where I discuss this, it's expanded to include more red or orange flags (it's in its probably third or fourth iteration now), but there's a nice table in the article that goes over some of these red and orange flags. It includes things like systemic feature (like headache, nuchal rigidity), if there's a history of cancer, if there's associated, you know, headache waking child up in the morning with vomiting - and a variety of features. I have to say the level of evidence for some of the features is relatively low, and our understanding of some of the red flags has changed over time. As one example, we used to think occipital headaches in youth were almost always associated with a secondary headache disorder, but now there's more emerging data to show that it's actually relatively common for youth with migraine to have an occipital location. So, really, using the tool is about kind of putting the whole picture together to try to risk stratify. In the majority of youth who present with recurrent headaches, who don't have any red or orange flags, and who have an unremarkable neurological examination without focal deficits, it typically is such that we don't have to do further investigation - but any red or orange flags (or a combination of them), any focal deficits on exam, would typically be where we would be considering neuroimaging. It's very unusual that we have an indication to do an EEG or large amounts of blood work in youth with headache, but it is context specific - for example, a case presenting with recurrent hemiplegia (you may have Todd's paralysis on the differential and you may want to do an EEG), or in a youth who also has GI symptoms (I picked up some youth with celiac disorder who have chronic headaches as well). So there are specific circumstances where blood work, EEG may be indicated (or obviously lumbar puncture in the case of suspected infection, et cetera), but for the most part, we're really relying on a very thorough history and physical exam to sort out our pretest probability of a secondary headache disorder and whether we need to do neuroimaging and further investigations. Dr Weathers: I think keeping in mind that systematic approach and really working through the algorithm is really reassuring and makes sense that, one, you won't miss something kind of worrisome, but on the other hand, that you're also not doing unnecessary testing, either. Along those lines, what do you think is the easiest mistake to make when treating children and adolescents with headache, and how do you avoid it? Dr Orr: I think the easiest mistake to make is undertreatment. Both for acute and preventive therapies, I often see undertreatment. I think families are often hesitant to give medication to their children, and so I have a lot of families say, “Oh, well, you know we typically wait the attacks out until they get more severe, we try to avoid medication, we use cold compresses, et cetera.” So, explaining to families that acute treatment (of course, we don't want to overuse it) and overusing simple analgesics (NSAIDS) more than three days a week can increase the risk of higher frequency of attacks and medication overuse headache - but undertreatment is a risk, too. And the way I like to explain it to families is in the scientific basis of pain chronification - so I'll say to families, “You know, we have these pain pathways in our brain. If we let them go off for long periods of time, they get stronger (and so that's where we want to get medication in quickly to try to shorten the exposure of the attacks). When you don't do that, those pain pathways may start out like a dirt road - and maybe then you have lots of long attacks, and then it gets paved, and then it becomes a highway.” I find it's a useful way to help families understand the concept of pain chronification and why we want them to treat attacks. The same thing goes for undertreatment on the preventive side. If you know a youth is having frequent attacks that are impacting their life and their ability to function, we really should be thinking about a daily preventive treatment, because we know that pill-based interventions will result in a significant reduction in headache frequency in at least two-thirds of youth - and again, allowing the youth to have frequent attacks contributes to that pain chronification (and explain it to families in a similar way to what I just explained for acute treatment) - but there can be a lot of hesitancy to engage with pill-based treatments, even though we know that they can be helpful. Dr Weathers: I think that's a really powerful point - and I think something we also, frankly, probably tend to do on the adult side as well – but, especially, I could see where there's even probably more hesitancy in children and adolescents (this concern that we're going to overtreat them and then end up inadequately treating, which leads to increased problems). And also goes back to the concept you were talking about earlier about the importance of shared decision-making and really engaging with the patient and their families in the discussion early on to help avoid that, as well to have everybody aware of the benefits and the side effects of all of the different options, I think is so critical. I was also really excited to see you (in the article) write about the importance of a trauma-informed care approach. This is an area I'm really passionate about in my work as a clinical informaticist and how we can leverage the electronic health record to support trauma-informed care and raising awareness of what a patient's triggers may be. Can you explain to our listeners who may not be knowledgeable about this approach what it means, and why you think that this might be applicable to children adolescents with headache? Dr Orr: Thanks for bringing that up. I think it's really important as well. We've done some work in my lab (and many others have as well) to show that there's a relationship between adverse childhood experiences and the development of headache disorders in youth and adults. By adverse childhood experiences, I mean exposure to highly stressful (like toxic stress) environments in early childhood, such as experiencing death of a parent, divorce, abuse, neglect. So, we know that adverse childhood experiences are associated with higher risk of developing migraine and headache disorders, and knowing that and how common these are amongst our patients - really think it's important to advocate for screening all children, adolescents coming in with recurrent headaches for adverse childhood experiences and exposure to trauma, because it really will impact not only how you interact with the patient, but also potentially what you will screen them for on the mental health side. And so providing trauma-informed care, I think - of course we want it to be targeted - but really taking this approach with all patients is actually a good way to think about it, because trauma is very common in our society, and some of the ways that we've measured trauma in the past (like some of the examples that I gave, divorce, death of a parent) are really narrow and don't encompass broader aspects of trauma (like systemic racism and other things that people are experiencing that haven't been adequately measured). So what trauma-informed care is - you know, there's a few core aspects, and one is screening all patients for trauma. The way I do that in clinic is just asking them if they've had any major stressful life events (and then I give a few examples), but there are standardized questionnaires that can be used for this as well. And then really trying to develop a nurturing rapport with the patient - an open listening strategy, asking open-ended questions, being empathic with patients and families - I know we all try to do this, anyway, but really focusing on that, especially in the context of trauma. And then thinking carefully about not only how you're talking to the patient, but how you're approaching them during the physical exam (so, for example, asking permission before touching the patient rather than just diving into the exam to be sensitive to that). And then also recognizing, like I said, that some of the ways that we've conceptualized trauma have been a little bit narrow, and that trauma may occur in context outside of what we traditionally think of. Dr Weathers: Again, I think that's so important and could be certainly much more broadly applied than even just to this one field, but thrilled to see that you're incorporating it into your work and your research (and again, it was discussed in the article) - and, absolutely, I think that the more that we incorporate it as well here, I think, that the better off for all of our patients and the improved care we provide. Moving on from that, I always like to end my interviews on a positive and hopeful note, and so I'd love to hear from you what you're most excited about in the field of pediatric headache. What breakthroughs do you think are coming, or what's giving you the most hope? Dr Orr: There's so much, there's so much exciting stuff going on in our field (and so, you know, I'll have to rein in myself in here), but one thing is there's been an explosion of novel treatment options on the adult migraine side in the last five to ten years, including agents targeted at the CGRP pathway, calcitonin gene-related peptide, some monoclonal antibodies, and receptor antagonists. There's been an explosion of neuromodulation options with now five devices that have various levels of FDA clearance for use in adults and/or youth with migraine. And there are, for most of these devices and novel drugs, either published studies or ongoing research into how they may be used in youth, so I'm hopeful that we will have more treatment options that are evidence based for youth going forward. This is in part due to the Pediatric Research Equity Act that came out a couple of decades ago now that has put requirements for pediatric studies when new drugs are approved by the FDA for adults - so I think that has had an impact, and I'm hopeful that we'll have an expanded treatment landscape in the years to come. There's also a lot of really exciting, more kind of fundamental research going on that I think will help us move the pediatric field forward more rapidly. In the past, we have really often borrowed from what the adult neurologists are doing for adults with headache disorders without really understanding some of the fundamental biological and psychosocial differences between headache disorders onset in youth versus adulthood, and so there is more and more research going on to understand the biology of migraine in youth and some of the risk factors at this age and some of the features that may make youth a little bit different, because it's very rare that youth are just little versions of adults for any disease or problem. And then, you know, I've seen a really large expansion in the number of trainees who are interested in headache medicine since I've entered this field (I've even got one of our residents who's going to do a headache fellowship, which is exciting), and seeing the growth and interest in headache medicine and the number of people being trained really gives me a lot of hope for the future, because there's so much work to be done in this area, and, really, that's where we're going to have the largest impact - is in mentoring and fostering the next generation of headache neurologists. So, there's lots of reasons to be excited, and I would say to the trainees listening that if you want an exciting career where there's lots of opportunity to make impact both clinically on your patients and in terms of educating the next generation and spearheading research initiatives, headache medicine is for you. Dr Weathers: I think that is incredibly inspiring and will hopefully get a lot of our listeners excited about joining this incredible field. Well, thank you for, again, this great article and for all of your time this evening, I've learned so much and really enjoyed speaking with you. Dr Orr: Thank you. Likewise, it was great to have this opportunity. I really enjoyed it.   Dr Weathers: Again, today, we've been interviewing Dr. Serena Orr whose article on pediatric headache appears in the most recent issue of Continuum on headache. Be sure to check out Continuum Audio podcasts from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practice. And right now, during our Spring Special, all subscriptions are 15% off. Go to Continpub.com/ Spring2024, or use the link in the episode notes, to learn more and take advantage of this great discount. This offer ends June 30, 2024. AAN members: go to the link in the episode notes and complete the evaluation to get CME. Thank you for listening to Continuum Audio.

Cluster B This show aims to educate the audience from a scientifically informed perspective about the major cluster B personality disorders: narcissism, histrionic, borderline, and antisocial. References:  Hengartner, M. P., Ajdacic-Gross, V., Rodgers, S., Müller, M., Haker, H., & Rössler, W. (2014). Fluid intelligence and empathy in association with personality disorder trait-scores: Exploring the link. European Archives of Psychiatry and Clinical Neuroscience, 264(5), 441–448. https://doi-org.mylibrary.wilmu.edu/1... Furnham, A. (2006). Personality disorders and intelligence. Journal of Individual Differences, 27(1), 42–46. https://doi-org.mylibrary.wilmu.edu/1... Bédard, M.-A., & Le Corff, Y. (2019). Intelligence and personality: A replication and extension study of the association between intelligence and personality aspects. Journal of Individual Differences. https://doi-org.mylibrary.wilmu.edu/1... Want more mental health content? Check out our other Podcasts: Mental Health // Demystified with Dr. Tracey Marks  True Crime Psychology and Personality Healthy // Toxic Here, Now, Together with Rou Reynolds Links for Dr. Grande Dr. Grande on YouTube Produced by Ars Longa Media Learn more at arslonga.media. Produced by: Erin McCue Executive Producer: Patrick C. Beeman, MD Legal Stuff The information presented in this podcast is intended for educational and entertainment purposes only and is not professional advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

The first of this episode's two case reports features a 62-yo man, referred from ophthalmology with a drooping eyelid, chronic coughing, and excess sweating in the face provoked by eating (1:21). An MR scan finds abnormal deposits in his brain - (link) The second report describes two patients (17:05), firstly a 70-yo man presenting with abnormal facial movements and weight loss, and secondly a 90-yo woman with abnormal movements of her right arm and leg. Routine blood tests at presentation for both patients were normal at presentation - (link) The case reports discussion is hosted by Prof. Martin Turner (1), who is joined by Dr. Ruth Wood (2) and Dr. Xin You Tai (3) for a group examination of the features of each presentation, followed by a step-by-step walkthrough of how the diagnosis was made. These case reports and many others can be found in the April 2024 issue of the journal. (1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital. (2) Neurology Registrar, University Hospitals Sussex. (3) Clinical Academic Fellow, Nuffield Department of Clinical Neurosciences, Oxford University, and Neurology Specialty registrar, Oxford University Hospital.  Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole. Thank you for listening. 

Welcome to the SYNC Your Life podcast episode #243! On this podcast, we will be diving into all things women's hormones to help you learn how to live in alignment with your female physiology. Too many women are living with their check engine lights flashing. You know you feel “off” but no matter what you do, you can't seem to have the energy, or lose the weight, or feel your best. This podcast exists to shed light on the important topic of healthy hormones and cycle syncing, to help you gain maximum energy in your life.  In today's episode, I interview Dr. Jess Lofgren, also known as "The Brain and Body Doc." Dr. Jess is a board certified functional neurologist, D.C., specializing in vestibular therapy, mind-body work, and root cause approach to health. Before obtaining her doctorate in chiropractic, she earned a Bachelor of Science, graduating cum laude, from Virginia Tech with a degree in Human Nutrition, Foods and Exercise. She graduated magna cum laude from Palmer College of Chiropractic and received both the Academic Excellence and Clinical Excellence Award. While in chiropractic school, she served as President of Functional Neurology Club, was a National Representative for the Motion Palpation Institute and an Executive Officer for Soft Tissue Club. She also worked as a teaching assistant for Activator Methods, where I earned my Level 1 certification in Activator Technique.  During her time in chiropractic school, she began her education in the field of Chiropractic Neurology with the Carrick Institute of Graduate Studies. Upon graduation, she received her Diplomate from the American Chiropractic Neurology Board and my Fellow from the American College of Functional Neurology. She now has over 800 hours in post-graduate education in Functional Neurology, including specialty training in Human Performance, Concussion, and Vestibular Disorders and have lectured to other doctors across the world on Clinical Neuroscience. Her passion for the study of human movement does not end in the field of chiropractic and medicine. She is also a certified 200-hour yoga teacher, allowing her to study human movement and the the effects of yoga on the nervous system and body from a unique perspective. She completed my 200 hour training in Bali, Indonesia with Yogakoh. You can find Dr. Jess at @thebrainandbodydoc on Instagram, or via her website at https://hellobrainandbodyco.com/.  In this episode, I reference my previous interview with Calie Calabrese, found here. I also reference Dr. Sarah Gottfried's newest book, "The Autoimmune Cure," which can be found here. You can access the free SYNC sample workout by joining the email list here: syncjennyswisher.com/fitness You can hear even more details about the SYNC fitness program in my Q&A with SYNC trainer Kelsey Lensman here. If you feel like something is “off” with your hormones, check out the FREE hormone imbalance quiz at sync.jennyswisher.com.  To learn more about the SYNC Digital Course, check out jennyswisher.com.  Let's be friends outside of the podcast! Send me a message or schedule a call so I can get to know you better. You can reach out at https://jennyswisher.com/contact-2/. Enjoy the show! Episode Webpage: jennyswisher.com/podcast 

This edition of Airing Pain focuses on the treatment of pain, the importance of catering treatment to a person's individual genetic makeup, and why addressing the psychological dimensions of pain is crucial in treating it effectively.  The process of finding a medication or treatment that works for a person often involves a lot of trial and error, which can be a frustrating process for someone to go through. This process can be side-stepped through the use of personalised medicine, where information about a person's genetic makeup is used to tailor and optimise their treatment so it is as effective as possible. Although medication is oftentimes a vital part of treating pain, incorporating psychological treatment alongside medication can be hugely beneficial when it comes to making pain management better for those living with acute or chronic pain. Changing how someone thinks about pain can enhance their response to the physical components of the treatment they receive. Our contributors for this edition discuss the ways in which the treatment of pain can be made more effective for people by incorporating personalised medicine or psychological treatments into a person's care plan. Please leave us a review on this platform or give feedback via our Airing Pain survey. Contributors: Professor Tony Dickenson, Professor of Neuropharmacology at University College London. Dr. Beth Darnall, PhD, Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine. Director, Stanford Pain Relief Innovations Lab. Professor Irene Tracey, Vice Chancellor of the University of Oxford and a Professor of Anaesthetic Neuroscience in the Nuffield Department of Clinical Neurosciences. Read transcript Thanks: This edition of was made possible thanks to funding from the Guy Fawkes Charitable Trust and support from the British Pain Society. Time Stamps: 1:11 Paul introduces Professor Tony Dickenson,who he spoke to at the British Pain Society Annual Scientific Meeting 2022. 3:21 Professor Tony Dickenson discusses ‘precision medicine', ‘personalised medicine', and how looking at peoples' genetic makeup can help medical professionals treat pain more effectively.  14:21 Paul introduces Dr Beth Darnall, who he spoke to at the British Pain Society Annual Scientific Meeting 2023. 14:54 Dr Beth Darnall explains the psychological components of how people experience pain. 20:24 Paul introduces Professor Irene Tracy, who he spoke to at the British Pain Society Annual Scientific Meeting 2023.  20:57 Dr Irene Tracy discusses the work she's done on neuroimaging and how the human brain constructs the experience of pain.  23:22 Paul and Dr Tracy talk about what neuroimaging tells us about the multidimensional way the human brain reacts to pain. 26:06 Beginning of discussion about Empowered Relief, a psychology-based intervention that provides people with skills and tools to help manage their acute or chronic pain.  26:31 Dr Beth Darnall discusses the psychological side of treating pain and how empowered relief is used to help people manage their pain. 29:10 Dr Beth Darnall talks about the psychological tools people learn through Empowered Relief and how they help with pain management.    Additional Resources: Airing Pain 100: Glasgow Pain Education Sessions Empowered Relief  Pain Matters 80: What treatment really works 

Multiple Sclerosis (MS) is a neurological disease which can lead to loss of mobility and vision. Almost 3 million people worldwide are affected by it. There is no cure, but attempts are being made to accelerate the healing process with treatments to restore what the disease has damaged.At the same time, scientists have recently discovered a link between MS and a common virus that the majority of us carry in our bodies. It had been known for years that there was a link between Multiple Sclerosis and Epstein-Barr virus (EBV). But then, a study finally proved the link.Now, trials are underway on potential vaccines against EBV and scientists are hopeful that this could be a gateway to preventing MS. This week on the Inquiry we are asking: Are we close to a breakthrough for Multiple Sclerosis?Contributors:Tim Coetzee, Chief Advocacy, Services & Science Officer for the National MS Society, US Tjalf Ziemssen, Professor of Clinical Neuroscience and Head of the Multiple Sclerosis Center and Neuroimmunological Laboratory, University Clinic Carl-Gustav Carus, Germany Jeffrey Huang, Associate Professor of Biology, Georgetown University, US Claire Shannon-Lowe, Associate Professor in Virology, Institute of Immunology and Immunotherapy at the University of Birmingham, UKProduction team: Presenter: Tanya Beckett Producer: Matt Toulson Researcher: Ajai Singh Editor: Tara McDermott Studio Manager: Hal Haines Production Co-ordinator: Liam MorreyImage Credit: ShidlovskiGetty

Découvrez le livre NEUROSAPIENS ! Pour apprendre à créer rapidement et à moindre coût son podcast, c'est par ici ! Recherches et écriture : Thaïs MarquesProduction, animation, réalisation : Anaïs RouxInstagram : https://www.instagram.com/neurosapiens.podcast/neurosapiens.podcast@gmail.comProduit et distribué en association avec LACME Production.Références : Crone, E. A., & Konijn, E. A. (2018). Media use and brain development during adolescence. Nature Communications, 9(1), 588. https://doi.org/10.1038/s41467-018-03126-xDienlin, T., & Johannes, N. (2020). The impact of digital technology use on adolescent well-being. Dialogues in Clinical Neuroscience, 22(2), 135–142. https://doi.org/10.31887/DCNS.2020.22.2/tdienlinHarris, B., Regan, T., Schueler, J., & Fields, S. A. (2020). Problematic Mobile Phone and Smartphone Use Scales: A Systematic Review. Frontiers in Psychology, 11, 672. https://doi.org/10.3389/fpsyg.2020.00672Odgers, C. L., & Jensen, M. R. (2020). Annual Research Review: Adolescent mental health in the digital age: facts, fears, and future directions. Journal of Child Psychology and Psychiatry, 61(3), 336–348. https://doi.org/10.1111/jcpp.13190Orben, A. (2020). Teenagers, screens and social media: A narrative review of reviews and key studies. Social Psychiatry and Psychiatric Epidemiology, 55(4), 407–414. https://doi.org/10.1007/s00127-019-01825-4Orben, A., & Blakemore, S.-J. (2023). How social media affects teen mental health: A missing link. Nature, 614(7948), 410–412. https://doi.org/10.1038/d41586-023-00402-9Orben, A., & Przybylski, A. K. (2019). The association between adolescent well-being and digital technology use. Nature Human Behaviour, 3(2), 173–182. https://doi.org/10.1038/s41562-018-0506-1Orben, A., Przybylski, A. K., Blakemore, S.-J., & Kievit, R. A. (2022). Windows of developmental sensitivity to social media. Nature Communications, 13(1), 1649. https://doi.org/10.1038/s41467-022-29296-3Panova, T., & Carbonell, X. (2018). Is smartphone addiction really an addiction? Journal of Behavioral Addictions, 7(2), 252–259. https://doi.org/10.1556/2006.7.2018.49Sherman, L. E., Greenfield, P. M., Hernandez, L. M., & Dapretto, M. (2018). Peer Influence Via Instagram: Effects on Brain and Behavior in Adolescence and Young Adulthood. Child Development, 89(1), 37–47. https://doi.org/10.1111/cdev.12838Sherman, L. E., Hernandez, L. M., Greenfield, P. M., & Dapretto, M. (2018). What the brain ‘Likes': Neural correlates of providing feedback on social media. Social Cognitive and Affective Neuroscience, 13(7), 699–707. https://doi.org/10.1093/scan/nsy051Smith, A. R., Rosenbaum, G. M., Botdorf, M. A., Steinberg, L., & Chein, J. M. (2018). Peers influence adolescent reward processing, but not response inhibition. Cognitive, Affective, & Behavioral Neuroscience, 18(2), 284–295. https://doi.org/10.3758/s13415-018-0569-5

Atypical Parkinsonian Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies are often initially diagnosed as Parkinson's disease. Incorrect, incomplete, or delayed diagnoses are barriers to beginning the most appropriate treatment early in the disease course. More research is needed to facilitate early diagnoses, understanding of disease pathogenesis, and monitoring of disease progression. However, largescale, collaborative initiatives are making meaningful progress in understanding genetic contributors to disease pathology and progression in Parkinson's disease. Our guest in this episode, Dr. Huw Morris, has spent more than twenty five years researching Parkinson's disease and parkinsonian syndromes, and he shares highlights from recent work, including studies on the genetics and pathogenesis of Parkinson's disease and other parkinsonian syndromes. Huw is Professor of Clinical Neuroscience at University College London Institute of Neurology, as well as an Honorary Consultant Neurologist at the Royal Free Hospital and the National Hospital for Neurology and Neurosurgery Queen Square. This podcast is geared toward researchers and clinicians. If you live with Parkinson's or have a friend or family member with PD, listen to The Michael J. Fox Foundation Parkinson's Podcast. Hear from scientists, doctors and people with Parkinson's on different aspects of life with the disease as well as research toward treatment breakthroughs at https://www.michaeljfox.org/podcasts.

Welcome to a new episode of |Theb ADHD Women's Wellbeing Podcast! Have a look at some of Kate's workshops and free resources here. Check out all the ADHD Hormone Series Workshops here.This is one of the most inspiring and empowering episodes I've recorded. We are at the cusp of new understandings about combining medical disciplines so we can understand ADHD in girls and women better through the lens of both hormones and psychiatry. This is for the lost generation of women who never got answers and for the future generations of girls who deserve better medical knowledge and research. This week's guest is Dr Lotta Borg Skoglund. Lotta is an associate professor in psychiatry at the Department of Women and Children's Health at Uppsala University and an affiliated researcher at the Department of Clinical Neuroscience at Karolinska Institutet. Her scientific work and research target the intersection of ADHD and comorbidity conditions (substance use disorders, personality disorders and mood disorders) as well as gender discrepancies and hormonal factors associated with neurodiversity and ADHD. She is the author of six popular science books on ADHD and addiction, and her book ADHD Girls to Women - Getting on the Radar has been translated into several European languages, English and Korean.On this episode of the ADHD Women's Wellbeing Podcast, Dr Lotta Skoglund and Kate spoke about:Dr Lotta's ADHD diagnosis ADHD purposeThe Seven ADHD lifestyle factors we need to think about dailyThe Letterlife app initiative and research Feeling abandoned by healthcare professionals after an ADHD diagnosis Why healthcare professionals should be working together to help patientsHow an understanding of ADHD can change your health outcomesBuilding autonomy to feel more empowered with our ADHDImproving female-based medical research and ADHDThe importance of talking about your experiences with hormones to help othersPrecision and patient-led medicine Connecting Hormones and Psychiatry to help more ADHD womenWhy fluctuating hormones and cycles need to be part of the bigger health picture Getting to know your unique hormone cycle traitsHow you can create a personalised health journal You can learn more about Lotta's work via her website, www.borgskoglund.com and Letterlife.Kate Moryoussef is a women's ADHD Lifestyle & Wellbeing coach and EFT practitioner helping overwhelmed and unfulfilled newly-diagnosed ADHD women find more calm, balance, hope, health, compassion, creativity and clarity. Follow the podcast on Instagram here.Follow Kate on Instagram hereFind Kate's resources on ADDitude magazine here

Episode Resources:  The Tenacious Brain: How the Anterior Mid-Cingulate Contributes to Achieving Goals - PMC (nih.gov) The Neuroscience of Willpower with David Goggins & Dr. Andrew Huberman (futuredoctor.ai) Anterior Cingulate Cortex: Unique Role in Cognition and Emotion | The Journal of Neuropsychiatry and Clinical Neurosciences (psychiatryonline.org) David Goggins: How to Build Immense Inner Strength | Huberman Lab • Podcast Notes A Tale of Two Nails | Psychology Today   In this episode, we dive deep into the fascinating world of the brain, focusing on a key player in our mental and emotional landscape: the anterior mid-cingulate cortex (aMCC). Known for its integral role in cognitive control, emotional regulation, pain processing, and decision-making, the aMCC is a cornerstone of our neural architecture that responds and adapts to the challenges we face. But what happens in our brain when we push our limits and step outside our comfort zones? Join us as we explore how tackling difficult tasks not only strengthens the aMCC but also enhances our overall brain function, making us more resilient to stress and better equipped to handle fear and anxiety. We'll unravel the science behind neuroplasticity and how engaging in challenging activities can lead to significant improvements in our cognitive and emotional abilities. But it's not just about the hard stuff; it's also about our perception of stress and fear in our lives. Often, we magnify these feelings, allowing them to dictate our actions and mindset. This episode sheds light on the importance of stress and fear, discussing how these emotions are not the giants we often make them out to be. Instead, they are essential components of our survival toolkit, designed to alert us but not immobilize us. Through personal anecdotes, and the latest scientific research, we'll provide you with actionable insights on how to harness the challenges you face to strengthen your brain and transform your approach to stress and fear. Whether you're looking to boost your mental agility, enhance your emotional resilience, or simply curious about the incredible adaptability of the human brain, this episode is for you. So, plug in, tune out the noise, and discover how doing hard things can lead to significant growth, not just in the anterior mid-cingulate cortex, but in every aspect of your life. Let's embark on this journey of discovery and empowerment together!

Do you feel like "hibernating" in the winter months? Does the loss of daylight affect your mood? Regardless of whether you tough it out in the northern US in cold winter conditions, or you escape to warmer temperatures down south, none of us are immune to seasonal changes in the amount of daylight hours. The winter solstice comes for us all, whether you're in Fargo or Fort Lauderdale. Have you ever wondered if you had “seasonal affective disorder”? (As an aside, it's either genius, or a giant bummer that the acronym for this condition is “SAD”).  Today's episode talks all about seasonal affective disorder! Who gets it? Why? How can we treat and/or prevent it? Does staring into a light box actually work? Are medications helpful for SAD? What about behavioral therapy? What does the research show? Bonus topic at the end, Jeremy dives into the recent rise in measles cases in the US, and gives some context as to why that trend may be occurring. We give a brief overview of measles, and clarify the "controversy" over the MMR vaccine (Andrew Wakefield, cough, cough...) Resources for this episode include: The National Institute of Health website for Seasonal Affective Disorder. A 2007 article from Dialogues in Clinical Neuroscience titled "The phase shift hypothesis for the circadian component of winter depression". The American Family Physician article from 2012 titled "Seasonal Affective Disorder". The Mayo Clinic website re: choosing a lightbox for SAD. A link to the Rohan et al study published in the American Journal of Psychiatry comparing light therapy to cognitive behavioral therapy for treatment of SAD. AND YOU CAN'T MISS this clip of the wonderful Meteorologist (Chicago's Very Own) Tom Skilling feeling overcome with emotion watching a total solar eclipse in 2017 :) Tom Skilling is so pure, we do not deserve him! Thanks for tuning in, folks! and please sign up for our "PULSE CHECK" monthly newsletter! Signup is easy, right on our website page, and we PROMISE we will not spam you! We just want to send you cool articles and thoughts :) For more episodes, limited edition merch, or to become a Friend of Your Doctor Friends (and more), follow this link! This includes the famous "Advice from the last generation of doctors that inhaled lead" shirt :) Also, CHECK OUT AMAZING HEALTH PODCASTS on The Health Podcast Network   Find us at: Website: yourdoctorfriendspodcast.com  Email: yourdoctorfriendspodcast@gmail.com  Connect with us: @your_doctor_friends (IG) Send/DM us a voice memo/question and we might play it on the show! @yourdoctorfriendspodcast1013 (YouTube) @JeremyAllandMD (IG, FB, Twitter) @JuliaBrueneMD (IG) @HealthPodNet (IG)

Have you ever wondered how the natural power of sunlight could be harnessed to boost our health?  In this episode of the Biohacking Superhuman Performance podcast, I chat with Sarah Turner about red light therapy. Together, we unpack the science that underlies the interaction of red light with our bodies, discuss numerous benefits it may offer for various health conditions, and the crucial aspect of tailoring the dosage for optimal results. Sarah explains the gut-brain connection and how red light therapy might be beneficial for our microbiome Sarah also discusses the concept of structured water and its influence on our health. She explains how light can alter the structure of water and consequently impact our bodies.  To top it all off, we'll share some fascinating case studies and discuss an innovative device designed for brain health that overcomes the barrier presented by the skull.  Sarah obtained degrees in Psychological Sciences and Nutritional Medicine, with a Post Graduate qualification in Clinical Neuroscience. She has studied many techniques both orthodox and alternative, with one goal in mind – to improve and optimise brain wellness and prevent brain related disease.  Whilst in California, Sarah became involved with the Biohacker movement. This led to her current understanding of the overriding role of physics in biology and fuelled her fascination with light and its healing effect on the body and mind.    Thank you to our sponsors for making this episode possible: Pendulum: Visit www.pendulumlife.com/nat to shop. No code necessary. LMNT: Visit DrinkLMNT.com/NAT - no code needed Mitopure: Use code NAT10 for 10% off at https://www.timelinenutrition.com/shop/nutrition.   Find more from Nathalie: YouTube: https://www.youtube.com/channel/UCmholC48MqRC50UffIZOMOQ Facebook Group: https://www.facebook.com/groups/biohackingsuperhumanperformance Instagram: https://www.instagram.com/nathalieniddam/ Website: NatNiddam.com Join Nat's Membership Community: https://www.natniddam.com/bsp-community Work with Nat: Book Your 20 Minute Optimization Consult: https://calendly.com/nniddam/intro-call?month=2021-08   Find more from Phil: Website: https://profound-health-summit.com/  What we discuss:   (00:03) - Bioregulator Peptides and Their Health Impact (09:17) - The Concept of Biological Age Control (22:06) - Bioregulators (32:05) - Melatonin and Immune Bioregulators in Cancer Treatment (39:46) - Stem Cell Therapy and Regenerative Medicine (53:30) - GHRPs and Growth Hormone Rejuvenation (01:03:24) - GHRP2 and Medical Foods  

At this point, most of you know about red light therapy and all the amazing benefits that come with it. That's why in this episode, we are going to look at it from a different perspective. Rather than focusing solely on the common uses of red light therapy, we'll dive into its potential in enhancing brain health and cognition function, managing conditions like Parkinson's disease, altering your microbiome, and enhancing the connection between your gut and brain. We'll also dive into the lesser-known areas of this therapy such as its influence on structured water and so much more.  We go deep into individual case studies, current trials, and the role of dosing considerations in red light therapy to accentuate the fact that red light therapy is one of the most underrated yet powerful tools and can do some amazing things for healing and optimization – far beyond what most of us realize! Sarah is the co-founder and CEO of Ceratrhive, a company that develops a very special kind of red light therapy devices that we will also discuss in this episode. She has a postgraduate degree in Clinical Neuroscience from Roehampton University in London. She also holds BSc degrees in Psychological Sciences and Nutritional Medicine from Westminster University and Thames Valley University, respectively. Currently, she is pursuing a diploma in Photobiomodulation at the University of Montpellier in France. During the initial decade of her career, Sarah worked as a research scientist in the pharmaceutical industry. Her role involved planning and conducting experiments to examine the impact of electrostatics on physiology.   Thank you to our sponsors for making this episode possible: Carol Bike: Visit carolbike.com and use promo code NAT for $100 off. LeelaQ: Go to www.leelaq.com and use code NATHALIE10  Profound Health: Visit www.profound-health.com and use code longevity15 to save 15% off your first order. Find more from Nathalie: YouTube: https://www.youtube.com/channel/UCmholC48MqRC50UffIZOMOQ Facebook Group: https://www.facebook.com/groups/biohackingsuperhumanperformance Instagram: https://www.instagram.com/nathalieniddam/ Website: NatNiddam.com Join Nat's Membership Community: https://www.natniddam.com/bsp-community Work with Nat: Book Your 20 Minute Optimization Consult: https://calendly.com/nniddam/intro-call?month=2021-08   Find more from Sarah: Website: https://www.cerathrive.com/ Instagram: https://www.instagram.com/cerathrive/  Facebook: https://www.facebook.com/CERASystem  What we discuss: (00:02) - Red Light Therapy and Its Benefits (11:58) - Dosing Considerations in Red Light Therapy (15:33) - Red Light Therapy for the Brain (24:14) - Structured Water and Its Biological Implications (33:21) - The Gut-Brain Connection and Light Therapy (40:47) - Parkinson's Trial and Brain Health Device (49:15) - Red Light Therapy Case Studies   Key takeaways:   Nature's red light therapy dosing is complex, with factors like power output, treatment time, and individual differences to consider for optimal results. Ongoing research on the effects of red light therapy demonstrates its potential to improve cognition in individuals with Down syndrome and alleviate symptoms of major depressive disorder. Specific devices have been designed for use on the head, as the skull presents a barrier for the light to penetrate. When we apply red light to the lower abdomen, it can benefit the microbiome and overall gut health. This is due to the red light therapy targeting the vagus nerve, blood cells, and even fat cells.   

Can blue light blocking glasses help prevent migraines? For many people who suffer from migraines, sensitivity to light (aka photophobia) is a debilitating piece of the migraine experience. To answer this question, we have to understand a little bit more about how your eyes work, the role blue light plays, and the nerdiest of nerdy cells in your eye - ipRGCs. While the science might not have definitive proof on blue light blockers and migraines, I know there are many people who have found blue light-coated lenses to be super helpful. But do they actually work and are they worth it? So whether you're a seasoned migraine warrior or just curious to learn more about blue light blockers and how they work - today's episode is for you! You'll learn: The connection between migraines and blue light If blue light blocker glasses are a valid preventative for migraines And the 3rd type of cell in your eye that you've never heard about All the links: Thin-film optical notch filter spectacle coatings for the treatment of migraine and photophobia." Journal of Clinical Neuroscience 28 (2016) Phototransduction in ganglion-cell photoreceptors. Pflugers Arch - Eur J Physiol 454, 849–855 (2007) Diagnosis, pathophysiology, and treatment of photophobia. Survey of ophthalmology 61.4 (2016) Join me for the Movement Mavens Retreat! www.aewellness.com/retreat/ 30 days to more strength + flexibility with the Mobility Mastery Toolkit www.aewellness.com/podcast - Show notes, links and more. Come hang out with me on Instagram @hollaformala : https://instagram.com/hollaformala/ TikTok @ aewellness Bodywork Starter Guide - learn the 6 places you need to roll right now for quick relief, plus the reason why what you've tried so far has only given you a temporary fix. Download the guide for free now at www.aewellness.com/bodywork 818-396-6501 is the Body Nerd Hotline - how do you build consistency and/or where are you getting stuck? Drop me a line and let me know your body nerd hacks - you might just hear your voice on a future episode! Today's episode is brought to you by Mobility Mastery Toolkit. Forget icing and stretching - and get a simple program you can do on your own that actually works. The Toolkit includes 30-days of exercises so you know exactly what to do to improve the mobility of your hips, lower back, feet, neck and shoulders. With video demos and a full-body mobility workout calendar, you're just 15-mins a day from feeling stronger and more flexible. Get $20 off when you use the code MASTERY at www.mobilitytoolkit.co

Hippocrates himself said that 'all disease begins in the gut' and today's guest, Sarah Turner, is taking that to the next level by optimizing the health of the gut-brain axis via photobiomodulation. Sarah has been working tirelessly the last couple of years to produce the first product of its kind, CERA, which is specifically engineered to emit particular frequencies of red and near-infrared light to both the gut and cranium to create a powerful effect of healing, wellness and optimization. Along with learning about Sarah and her journey to becoming the CEO and Co-Founder of CeraThrive, we engage in some stimulating, "geeking out" of numerous topics surrounding red light therapy, including the importance standardization in the photobiomodulation research and the industry as a whole and the importance and nuances of third party testing. Sarah also shares her thoughts on some potential synergistic supplements that may have a beneficial interaction with light and her excitement about combining methylene blue with red light therapy. ​​Sarah Turner has a postgraduate degree in Clinical Neuroscience, holds BSc degrees in Psychological Sciences and Nutritional Medicine and is currently pursuing a diploma in Photobiomodulation at the University of Montpellier in France. During the initial decade of her career, Sarah worked as a research scientist in the pharmaceutical industry. Today, Sarah's primary focus lies in photobiomodulation, which involves utilizing specific light wavelengths and pulsed frequencies to enhance optimal functioning, with a specific emphasis on brain-related issues. As the Co-Founder and CEO of CeraThrive, she spearheads the production of a red light therapy system that specifically targets the gut-brain connection.This episode is a classic conversation between two red light therapy nerds that have a passion for learning and improving the space for the better and, ultimately, helping people improve their health via light.​   With that said, learn lots and light up your health! - Key points: Introduction of Sarah Turner and her background in photobiomodulation: (00:00:00 - 00:01:43) Transition from pharmaceutical research to holistic approaches: (00:01:43 - 00:02:14) Emphasis on accessible photobiomodulation devices and education: (00:02:14 - 00:02:52) Addressing the lack of precise research parameters: (00:02:52 - 00:03:36) Advocating for standardized measurements in PBM protocols: (00:06:53 - 00:09:00) Importance of accurate third-party testing for PBM devices: (00:13:00 - 00:34:57) Standardization efforts in red light therapy: (00:38:24 - 00:42:39) Introduction of Bio Blue and its benefits: (00:42:39 - 00:43:20) Synergistic effects of supplements with red light therapy: (00:50:11 - 00:53:35) Focus on brain optimization, gut-brain connection, and microbiome support: (00:53:35 - 01:06:03) Contraindications for light therapy: (01:06:15 - 01:17:06) Benefits of red light therapy for eye conditions: (01:17:06 - 01:22:46) - Learn more about Sarah Turner:Cerathrive.com RebelScientist.com LinkedIn: Sarah Turner Instagram: @CeraThrive - Watch this episode on YouTube - Exclusive discounts on BioBlue and CERA products for The Red Light Report listeners — discount provided in episode! - Kindle version of Red Light Therapy Treatment Protocols eBook, 4th Edition - To learn more about red light therapy and shop for the highest-quality red light therapy products, visit https://www.biolight.shop - Dr. Mike's #1 recommendations: Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Instagram YouTube Facebook

Dr. G from Resiliency Brain Health joins me on the Podcast, In today's episode, we are honored to welcome Dr. Scharlene Gaudet, an esteemed leader in the field of brain health. As the Founder and Clinical Director of Resiliency Brain Health, Dr. Gaudet has an extensive educational background that includes a Doctorate of Chiropractic and a Bachelor of Science from Parker University. Her expertise is enhanced by a Diplomate in Functional Neurology from the American Board of Chiropractic Neurology and a Master's in Clinical Neuroscience. Dr. Gaudet has made significant strides in empowering women in the medical field, evidenced by her pioneering the first all-women's adjusting seminar at Parker University. Her enthusiasm for supporting veterans is inspired by her family's military history and her active involvement with various nonprofits that assist veterans and their families. Her current focus at Resiliency Brain Health is directed toward cutting-edge care in traumatic brain injury, neuro-orthopedic rehabilitation, and the treatment of neurodegenerative and metabolic disorders. A commitment to resilience and recovery drives Dr. Gaudet's contributions to brain health. For more insights into her innovative work, visit Resiliency Brain Health. We extend our sincere gratitude to our sponsors for their unwavering support of the VinnyRoc Podcast. Their commitment enables us to deliver content that informs, educates, and engages consistently.   Core Medical Group: Striving to pioneer in wellness solutions and help you achieve optimal well-being. Visit https://www.coremedicalgrp.com to discover more. GMR Gold: Offering premium gold and silver investment options to elevate your wealth. Explore more at https://www.gmrgold.com. Everest: The ultimate marketplace for the great outdoors. Embark on your adventure today at https://www.everest.com. Modern Gun School: Dedicated to enriching your firearms knowledge with a comprehensive curriculum. Find out more at https://mgs.edu.   We value the contribution of each sponsor and appreciate their dedication to our shared goals.   For those who haven't yet, we invite you to watch our latest episode on YouTube, subscribe to our channel, and follow us on social media to stay updated on upcoming content. If you find our discussions valuable, please share them within your networks.   Thank you for your continued support of the VinnyRoc Podcast.   #VinnyRocPodcast #ThankYouSponsors  

The rates of developmental delays, ADD, ADHD, and conditions like autism are on a steep rise. Parents of children who receive a diagnosis may think that there are no options for treatment. But our guest today, Dr. Josh Madsen, is changing that.He is proving to parents from all over the country that there IS hope and there are effective, simple treatments to improve their child's development, learning, and overall health.Dr. Josh Madsen has studied hard and continues to grow and learn so as to best equip himself to better use functional neurology, chiropractic, and functional medicine to help children heal and find hope. He first received his undergraduate degree in Exercise Science from University of Northern Iowa. He then went on to become a Doctor of Chiropractic from Palmer College of Chiropractic. As he continued to learn more and grow his knowledge, he studied Neurodevelopmental Delays from Carrick Institute of Clinical Neuroscience and Rehabilitation, and Functional Neurology through Functional Neurology seminars, accredited through the National University of Health Sciences.We discuss:What kind of conditions Dr. Madsen treatsHow are primitive reflexes related to ADD, ADHD and autism?Cutting edge treatments: lights, lasers, hyperbaric oxygen tanksThe role of nutrition in child developmentWhat's causing the rise in autism?What ALL parents need to know about movementSimple tests for parents to use at homemuch more!WANNA HEAR YOUR VOICE ON OUR SHOW? Now you can send us voice memos on Speakpipe! Ask us a question or leave us a comment and we will play it in an upcoming show. Leave us a message here: https://www.speakpipe.com/TheMedicinPodcastCONNECT WITH DR. JOSH: Website / IG OUR LINKS + DISCOUNTSMushyLove Latte (discount: MEDICIN)Immune Intel AHCCOur favorite Reishi KING CoffeeWild Pastures Meat Subscription (discount: MEDICIN)Organifi (20% discount: MIMIFIT)See all our favorite products on The Medicin CabinetCONNECT WITH USOur websiteMimi's IG // Chase's IG // The Medicin IGSound from Zapsplat.com

Should you become an artist or an accountant? Did Sylvia Plath have to be depressed to write The Bell Jar? And what can Napoleon Dynamite teach us about the creative life? RESOURCES:"The Science of Why You Have Great Ideas in the Shower," by Stacey Colino (National Geographic, 2022)."So, You Think You're Not Creative?" by Duncan Wardle (Harvard Business Review, 2021)."The Correlation Between Arts and Crafts and a Nobel Prize," by Rosie Cima (Priceonomics, 2015)."Report: State of the American Workplace," by Gallup (2014)."Poverty Impedes Cognitive Function," by Anandi Mani, Sendhil Mullainathan, Eldar Shafir, and Jiaying Zhao (Science, 2013)."Forks in the Road: The Many Paths of Arts Alumni," by the Strategic National Arts Alumni Project (2011)."A Meta-Analysis of 25 Years of Mood-Creativity Research: Hedonic Tone, Activation, or Regulatory Focus?" by Matthijs Baas, Carsten K. W. De Dreu, and Bernard A. Nijstad (Psychological Bulletin, 2008)."The Relationship Between Creativity and Mood Disorders," by Nancy C. Andreasen (Dialogues in Clinical Neuroscience, 2008)."The Broaden-and-Build Theory of Positive Emotions," by Barbara Fredrickson (Philosophical Transactions of the Royal Society B, 2004)."Happiness and Creativity: Going With the Flow," by Mihaly Csikszentmihalyi (The Futurist, 1997).EXTRAS:"Why Are Rich Countries So Unhappy?" by No Stupid Questions (2022)."Do You Really Need a Muse to Be Creative?" by No Stupid Questions (2021)."Does All Creativity Come From Pain?" by No Stupid Questions (2020)."How To Be Creative," series by Freakonomics Radio (2018-2019)."How to Be Happy," by Freakonomics Radio (2018).Napoleon Dynamite, film by Jared Hess (2004).The Bell Jar, by Sylvia Plath (1963).Connections, game by The New York Times.